dawnpowell

943 POSTS 0 COMMENTS

BIBA Briefings: Henry V can inspire us to develop innovative techniques...

During a session on radiation protection technologies at the 2019 Transcatheter Cardiovascular Therapeutics (TCT) meeting (25­–29 September, San Francisco, USA), Lloyd W Klein (Rush Medical College,...

EACTS 2019: Leading cardiothoracic surgeon questions EXCEL trial’s conclusion

Cardiothoracic surgeon David Taggart (Department of Cardiac Surgery, University of Oxford, John Radcliffe Hospital, Oxford, UK) told delegates attending the 2019 European Association for...

FDA approves Evolut PRO+

The US Food and Drug Administration (FDA) has approved the Evolut PRO+ transcatheter aortic valve implantation (TAVI) system, which a press release states builds...

Cardiovascular News Issue 55—September 2019 US edition

In our September issue, we report on the top stories from the 2019 European Society of Cardiology (ESC) congress (31 August–4 September, Paris, France)....

Cardiovascular News Issue 55—September 2019

In our September issue, we report on the top stories from the 2019 European Society of Cardiology (ESC) congress (31 August–4 September, Paris, France)....

Cardiovascular News Issue 54—August 2019 US edition

The August issue of Cardiovascular News covers the top stories from EuroPCR 2019, looking at PCR statements on TAVI. We also review stakeholders' response...

Cardiovascular News Issue 54—August 2019

The August issue of Cardiovascular News covers the top stories from EuroPCR 2019, looking at PCR statements on TAVI. We also review stakeholders' response...

AtriCure agrees to buy LARIAT developer SentreHEART

AtriCure has entered into a definitive agreement to acquire SentreHEART, which developed the LARIAT device for left atrial appendage closure in patients with atrial...

Novel repositionable TAVI valve has acceptable early clinical outcomes

A new study indicates that the Meridian transcatheter aortic valve implantation (TAVI) valve (HLT) is associated with a 30-day mortality rate of 8% and...

ESC 2019: Registry study supports use of ICDs for primary prevention...

New data from the SwedeHF heart failure registry indicates that the use of an implantable cardioverter defibrillator (ICD) in patients with heart failure with...

ESC 2019: Two-year findings of MITRA-FR continue to show no prognosis...

At the European Society of Cardiology Congress (ESC 2019; 31 August–4 September, Paris, France), Jean-Francois Obadia (Hopital Cardiovasculaire Louis Pradel, Chirurgie Cardio-Vasculaire et Transplantation...

ESC 2019: Ultrathin strut Orsiro better than thin strut Xience for...

One-year data from the BIOSTEMI study, simultaneously published in The Lancet and presented at the European Society of Cardiology Congress (ESC 2019; 31 August–4...

ESC 2019: Left atrial appendage closure is non-inferior to NOACS for...

This morning at the 2019 European Society of Cardiology (ESC) Congress (31 August–4 September, Paris, France), Pavel Osmancik (Charles University and University Hospital Kralovske...

ESC 2019: Prasugrel bests ticagrelor for the management of acute coronary...

Stefanie Schüpke (Deutsches Herzzentrum München, and Technische Universität München, Munich, Germany) told ESC delegates today that using prasugrel rather than ticagrelor to treat patients...

ESC 2019: Abiomed launches Impella SmartAssist platform

At the 2019 European Society Cardiology (ESC) congress (31 August – 4 September, Paris, France), Abiomed revealed that its Impella CP with SmartAssist technology is...

Poll favours interventional radiologists to perform mechanical thrombectomy in lieu of...

According to a BIBA MedTech survey, 52% of neurointerventionalists believe that they are the only specialists who have the relevant skills and experience to perform...

FDA approves Sapien 3 Ultra, Sapien 3, and CoreValve for low-risk...

On 16 August, the US Food and Drug Administration (FDA) approved Edwards Lifesciences’ Sapien 3 and Sapien 3 Ultra and Medtronic’s Evolut R and...

Edwards Lifesciences drops Centera in favour of focusing on Sapien range

Edwards Lifesciences—in a press statement announcing its global second quarter (Q2) financial results—has revealed that it is taking the self-expanding transcatheter aortic valve implantation...

Myval: India’s TAVI technology is now going global

The Myval transcatheter aortic valve implantation (TAVI) system, designed and manufactured by Meril Lifesciences in India, recently received the CE mark for the management...

Edwards Lifesciences to discontinue its self-expanding valve Centera

Edwards Lifesciences has announced it has made the “difficult decision” to discontinue its self-expanding transcatheter aortic valve implantation (TAVI) device Centera. The company says...

Edwards Lifesciences issues urgent safety notice for Sapien 3 Ultra

Edwards Lifesciences has issued an urgent safety notice for the latest generation of its Sapien device, Sapien 3 Ultra, after it received reports of...

Edwards Lifesciences issues an urgent field safety notice for Centera TAVI...

After receiving reports of difficulty tracking and manipulating the Centera transcatheter aortic valve implantation (TAVI) system around the aortic arch, Edwards Lifesciences has issued...

Zoll Medical acquires TherOx

Zoll Medical, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, has acquired TherOx—a company on improving treatment of acute...

Patent granted to Valfix Medical for its percutaneous valve and replacement...

Valix Medical has received a US patent—10,278,820 (percutaneous valve repair and replacement)—for its heart valve repair and replacement technology. A press release reports that...

Robotic PCI company adds interventional cardiology experts to its medical advisory...

Robocath has announced that that the well-known interventional cardiologists Michael Haude, Faziel Lorgat, and Holger Nef have joined its medical advisory board. Founded in...

Philips announces new advanced automation capabilities for its EPIQ CVx and...

A Philips press release reports both the EPIQ CVx and EPIQ CVxi now include automated applications for 2D assessment of the heart, as well...

India-designed Myval associated with no device-related mortality at one year

One-year data for the Myval transcatheter aortic valve implantation (TAVI) system indicate it is associated with 100% freedom from device related mortality at one...

Mentice and Siemens Healthineers aim to bring a virtual patient to...

Siemens Healthineers and Mentice have announced a collaboration to fully integrate Mentice’s Vist “Virtual Patient” into the Artis icono angiography system from Siemens Healthineers....

Nearly 50% of treatment strategies would change with use of investigational...

New data show that the use of the investigational HeartFlow Planner—a real-time, non-invasive interactive planning tool—led to a change in treatment strategy in 45% of...

DSM and SAT enter partnership to develop the first next-generation heart...

Royal DSM is to collaborate with Strait Access Technologies (SAT) to develop the world’s first durable and cost-effective transcatheter replacement heart valves with polymeric...

CMS’ update to coverage policy for TAVI provides greater flexibility for...

The Centers for Medicare & Medicaid Services (CMS) has finalised its update the US coverage for transcatheter aortic valve implantation (TAVI). It will continue...

New trial to compare Watchman FLX to direct oral anticoagulants

The OPTION trial is to compare the compare safety and effectiveness of the next-generation Watchman FLX left atrial appendage closure platform with first-line oral...

US$170m funding for Acutus Medical

A company providing what a press release calls “next-generation electrophysiology technology solutions” has announced that it now has US$170m financing. The press release reports...

Adrian Banning

Adrian Banning (John Radcliffe Hospital, Oxford, UK) initially wanted to fly a Boeing 747 but, aged nine, decided go into medicine instead. He talks...

TVT 2019: PASCAL system may be beneficial for managing tricuspid regurgitation

New data for the PASCAL system (Edwards Lifesciences), which received the CE mark in February 2019 for the management of mitral regurgitation, suggest it...

TVT 2019: Purpose-designed temporary pacing guidewire has potential to make implantation...

Speaking during an innovation session at TVT 2019 (12-15 June, Chicago, USA), Mark Hensey (Centre for Heart Valve Innovation, St Paul's Hospital, University of...

TVT 2019: TAVI is “preferred therapy” for low-risk patients

This morning at TVT 2019 (12-15 June, Chicago, USA), in separate presentations, the principal investigators of PARTNER 3 and Evolut Low Risk trials both...

EuroPCR 2019: Renal denervation linked to reduction in subclinical atrial fibrillation

Data presented at EuroPCR today indicates that renal denervation with the Symplicity system (Medtronic) is associated with a reduction in subclinical atrial fibrillation in...

EuroPCR 2019: Ultrathin stent demonstrates benefits in small vessels

Late-breaking trial data presented at EuroPCR 2019 (20–24 May, Paris, France) on three year outcomes of a substudy of patients with small vessel disease...

A “crackdown” on alternative access for TAVI

  The transfemoral approach is—by far—the most desirable access route for transcatheter aortic valve implantation (TAVI) for eligible patients; it was used in the TAVI...

Majority of cath labs feel burdens of PCI public reports outweigh...

Nearly two thirds (64.3%) of cath lab staff believe that the financial/administrative burdens of meeting percutaneous coronary intervention (PCI) public reporting requirements are not...

Less than half of vein graft interventions use embolic protection

Current US guidelines recommend the use of embolic protection during saphenous vein graft percutaneous coronary intervention (PCI) but, according to a new study, embolic...

Triage STEMI patients for ICU after PCI based on reperfusion timing

Patients with ST segment elevation myocardial infarction (STEMI) who undergo percutaneous coronary intervention (PCI) should be triaged for intensive care (ICU) treatment based on...

Vitros high-sensitivity troponin assay receives CE mark

Ortho Clinical Diagnostics has received the CE mark for its next-generation Vitros high sensitivity troponin I assay. A press release reports that this new...

NeoChord raises additional financing to drive catheter‐based programme development

NeoChord has announced that it has secured additional funding as an extension of its Series D equity financing, which was announced in November of...

Biotronik launches PK Papyrus covered coronary stent in the USA

Biotronik has launched the PK Papyrus covered coronary stent system in the United States for use in the emergency treatment of acute coronary perforations....

Lotus Edge becomes third TAVI device on US market

Boston Scientific has received US FDA approval for its Lotus Edge transcatheter aortic valve implantation (TAVI) system. It is approved for patients with severe...

US FDA approve SSO2 Therapy for the management of myocardial infarction

TherOx has received US FDA premarket approval for its SuperSaturated Oxygen (SSO2) Therapy. A press release reports that SSO2 Therapy provides interventional cardiologists with...

TAVI company Tioga Medical closes US$15M in series A financing

Tioga Medical—a newly formed Shifamed portfolio company—has announced the closing of its series A preferred stock financing, raising a total of US$15M. According to...

PhaseBio receives FDA breakthrough therapy designation for PB2452 for the reversal...

PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS) has announced that the US FDA has granted breakthrough yherapy designation for PB2452—a novel reversal agent for the antiplatelet...

Targeted blood pressure management helps to reduce strokes in patients with...

An analysis on the impact of stroke severity in patients receiving the HeartWare HVAD system (Medtronic) as destination therapy shows that targeted blood pressure...

CE mark for the FEops HEARTguide

FEops has received CE mark approval for its FEops HEARTguide. According to a press release, FEops HEARTguide is a one-in-its-kind procedure planning environment for...

Manage the risk of complications in CTO-PCI

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains one of the most demanding challenges for an interventional cardiologist. Technological developments have improved...

Reconciling the contrasting findings on MitraClip, and implications for the management...

Last year, the first two randomised controlled trials (RCT) looking at percutaneous edge-to-edge repair (MitraClip, Abbott) for the management of functional mitral regurgitation (MR)...

Comics may help patients to better understand coronary interventions

A pilot study, published as a research letter in the Annals of Internal Medicine, has found that patients who received comics or “medical graphic...

Prevalence of multiple organ failure among cardiogenic shock patients has steadily...

Between 2000 and 2014, in the USA, the percentage of patients with acute myocardial infarction cardiogenic shock (AMI-CS) who developed multiple organ failure increased...

ACC 2019: TAVI moves to the mainstream with new findings in...

Evidence for the use of transcatheter aortic valve replacement (TAVI) as standard therapy is mounting, with the release of data from two major new...

Robert W Yeh

Robert W Yeh (Department of Medicine, Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Harvard...

CRT 2019: Evolut R superior to surgery at one year in...

A subanalysis from the SURTAVI trial has found that transcatheter aortic valve implantation (TAVI) with Evolut R in intermediate-risk patients has lower rates of...

CRT 2019: Alert system is safe, quick, and has few complications

The AngelMed Guardian implantable device is as safe as using a pacemaker, with comparably low complication rates, and fewer delays in care than reliance...

MitraClip can be used to treat secondary mitral regurgitation in the...

The US FDA has approved a new indication for percutaneous edge-to-edge repair (MitraClip, Abbott), allowing its use for the reduction of moderate-to-severe or severe...

Micro Interventional Devices enters strategic alliance with Oscor

Micro Interventional Devices chairman, president and CEO, Michael Whitman, and Oscor president and CEO Thomas Osypka, are pleased to announce a strategic alliance that...

CardioCel 3D and VascuCel receive regulatory approval in Europe

Admedus has received the CE mark for its CardioCel 3D product portfolio and its next-generation collagen bioscaffold VascuCel in Europe. According to a press...

ACC to offer transcatheter valve certification to help hospitals implement best...

Beginning in mid-2019, hospitals performing transcatheter valve repair and replacement will be able to apply for the American College of Cardiology’s (ACC) new Transcatheter...

Northwestern Medicine Bluhm Cardiovascular Institute is pioneering the use of artificial intelligence (AI) for cardiac screening in a new study of Eko’s cardiac monitoring...

CRT 2019: Early resorption and low complications demonstrated for Magmaris

A press release reports that preliminary data from the BIOSOLVE-IV registry strengthen the clinical evidence in favour a bioresorbable magnesium scaffold (Magmaris, Biotronik) for...

Innovative cardiovascular systems announce first use of its next-generation Emblok embolic...

Innovative Cardiovascular Solutions (ICS) has announced the first clinical use of its next-generation Emblok embolic protection system in patients undergoing transcatheter aortic valve implantation...

Myocardial infarction patients taken directly to heart centres have better long-term...

Woman patient
According to a large observational study presented at Acute Cardiovascular Care 2019 (2–4 March, Malaga, Spain), myocardial infarction patients taken directly to heart centres...

CRT 2019: Three-year data shows trend towards lower target vessel failure...

Three-year outcome data from the BIO-RESORT randomised controlled trial, which were presented at the 2019 Cardiovascular Research Technologies (CRT) meeting (2–5 March, Washington, DC,...

CRT 2019: US FDA approves resting full-cycle ratio for measuring severity...

Abbott has announced the US FDA clearance of the resting full-cycle ratio (RFR) diagnostic test to identify significant narrowing of arteries in patients with...

CX 2019 to host first-ever aortic and peripheral virtual reality live...

The Charing Cross International Symposium (CX) continues its three-year cycle of raising vascular and endovascular controversies in order to challenge the available evidence and...

Customising therapy in femoropopliteal revascularisation

 Gary Ansel (Columbus, USA) tells Vascular News at VEITHSymposium 2018 about how drug-based therapies have become a mainstay in femoropopliteal revascularisation and how interventionalists...

Polymer-free stents have similar performance profiles, except in diabetes

A pooled data analysis comparing the Cre8 amphilimus-eluting stent (Alvimedica) and the BioFreedom biolimus-eluting stent (Biosensors) demonstrates similar safety and efficacy for the devices,...

Sapien 3 provides safe and satisfactory access via the transcarotid route

The Sapien 3 device (Edwards Lifesciences) can be safely and effectively used in transcatheter aortic valve implantation (TAVI) via the transcarotid approach in patients...

MedAlliance granted “breakthrough device designation” from FDA for its sirolimus-coated balloon

MedAlliance has been granted breakthrough device designation from the US FDA for Selution—a sustained limus release drug-coated balloon catheter for the treatment of coronary...

New Australian research and development partnership aims to innovate heart failure...

Biotronik, the University of Newcastle (in Australia), and the John Hunter New England Local Health District have partnered to shape a future heart failure...

American College of Cardiology to launch new journal dedicated to cardio-oncology

The American College of Cardiology will expand the Journal of American College of Cardiology (JACC) group of journals with the launch of JACC: CardioOncology...

Augmented reality surgical technology unveiled by Philips and Microsoft

At the MWC (25–26 February, Barcelona, Spain), formerly the Mobile World Congress, Philips unveiled a unique mixed reality concept developed in partnership with Microsoft for...

US physicians can now use Resolute to treat chronic total occlusions

Medtronic has received US FDA approval of its Resolute drug-eluting stent platform—including the Resolute Onyx and Resolute Integrity—for the treatment of patients with coronary...

CE mark for R-One robotic-assisted solution for treating coronary diseases

Robocath has obtained CE certification for its R-One robotic device. As a result, it can begin commercialisation in Europe and the Middle East. A...

FDA approves Orsiro for use in the USA

  The US FDA have approved Biotronik’s drug-eluting stent Orsiro. A press release states that Orsiro is the first and only ultrathin drug-eluting stent to...

ADVERTORIAL: The Edwards Cardioband™ Tricuspid Valve Reconstruction System is associated with...

This content is only for readers outside of the US as it discusses a device that is not FDA approved. Until recently, the tricuspid valve...

We need to embrace digital education and adapt it to improve...

Recent years have seen many advances in education for cardiologists, but little attention has been paid to the impact of new technologies, particularly digital...

Challenges of conducting a randomised clinical trials to prove the impact...

Mechanical circulatory support is frequently used to stabilise patient haemodynamics in desperate situations of circulatory failure to increase and maintain end organ perfusion.1 Of...

iVascular receives CE mark for Navitian microcatheter

After receiving the CE mark for the device, iVascular launched its Navitian coronary microcatheter on to the market. A press release reports that the...

CE mark for PASCAL mitral valve repair system

Edwards Lifesciences now has the CE mark for its PASCAL transcatheter mitral valve repair system. According to a press release, the system is designed for...

ACC to tackle patient, provider access to novel therapies

The American College of Cardiology (ACC) has launched a new initiative that leverages prospective clinical registry data and partnerships—spanning the pharmaceutical and medical device...

Philips launches Zenition mobile C-arm platform

Zenition
Philips Zenition, a new mobile C-arm imaging platform from Philips, has launched in the USA, Germany, Austria and Switzerland. It is being introduced into...

Rehab programme after myocardial infarction helps to reduce death

A programme designed to help myocardial infarction patients with the transition from hospital to outpatient care can reduce readmissions and deaths and increase the...

One in five US patients with atherosclerotic cardiovascular disease cannot pay...

A review, published in the Journal of the American College of Cardiology, of the financial hardship associated with atherosclerotic cardiovascular disease (such as coronary...

Long-term function of TAVI valves “is excellent”

Daniel J Blackman (Department of Cardiology, Leeds Teaching Hospital NHS Trust, Leeds, UK) and others report in the Journal of the American College of...

Leviticus Cardio and Jarvik Heart new fully implanted ventricular assist device

At a press conference held at the National Research Center for Cardiac Surgery in Astana (Kazakhstan), heart failure experts from around the world announced...

ADVERTORIAL Early results for HAART 200 and HAART 300 Aortic...

The Duke Children’s Pediatric & Congenital Heart Center (Duke University Medical Center, Durham, USA) treats the entire spectrum of patients with complex congenital heart...

The Tricento transcatheter heart valve: A novel approach for the treatment...

  In this commentary for Cardiovascular News, Stefan Toggweiler writes about how the Tricento device could address the current need in the management of tricuspid...

London hospital provides first video consultation service for specialist care in...

The Lewisham and Greenwich NHS Trust (London, UK) has become the first NHS Trust in England (UK) to offer video consultations for cardiology patients—enabling...

Less than a third of Americans known that cardiovascular disease is...

A new survey by HeartFlow of more than 1,500 adults across the USA shows only 29% of respondents know that heart disease is the...

Cardiovascular News Issue 52—February 2019 US edition

Our latest issue covers the top stories from TCT 2018, including COAPT, ULTIMATE, and FAST-FFR. We also profile Robert Yeh, interview David Kandzari about...

Cardiovascular News Issue 52—February 2019

Our latest issue covers the top stories from TCT 2018, including COAPT, ULTIMATE, and FAST-FFR. We also profile Robert Yeh, interview David Kandzari about...

US FDA grant premarket approval to Manta vascular closure device

Teleflex has received premarket approval (PMA) from the US FDA for the Manta vascular closure device. A press release reports that the device is...

First trial of in-heart micro device for left atrial pressure monitoring...

Vectorious Medical Technologies has announced the initiation of the VECTOR-HF first-in-human (FIH) clinical trial, and the successful first “in-human” implantation of the V-LAPTM monitoring...

PreludeSync distal compression device now available globally

The PrecludeSync Distal (Merit Medical) is now available in the US, European, Middle Eastern, African, and Asia-Pacific markets. The device is the first product...

Registry data for Biotronik’s bioresorbable scaffold Magmaris supports its roll-out into...

Preliminary data from the BIOSOLIVE-IV registry are consistent with the favourable safety outcomes seen with the magnesium bioresorbable scaffold (Magmaris, Biotronik) in previous studies...

ADVERTORIAL: “We are now at a new era of TAVI where...

CAUTION: The ACURATE neo aortic valve system is CE marked. In the USA, it is an investigational device—limited by US law to investigational use...

CE mark for cloud-based monitoring platform Impella Connect

Abiomed has achieved the CE mark for Impella Connect, which—a press release reports—is the first-of-its kind cloud-based technology that enables secure, real-time, remote viewing...

German NUB Status 1 designation for Neovasc Reducer renewed

Neovasc has announced that the Institut für das Entgeltsystem im Krankenhaus (InEk)— the German Institute for the Hospital Remuneration System—has awarded its Neovasc Reducer,...

Editors-in-chief of major cardiovascular journals claim medical misinformation puts “lives at...

The editors-in-chief of major cardiovascular journals—of both US and European societies—have come together to “sound the alarm” about the dangers of medical misinformation that...

The British Heart Foundation’s “Big Beat Challenge” is now accepting proposals

The British Heart Foundation (BHF) has announced that it is now accepting proposals for its Big Beat Challenge—a single funding award of £30 million. The...

FDA IDE approval for safety and feasibility clinical trial of Cor...

CorMatrix Cardiovascular has received US FDA approval of an early feasibility study investigational device exemption (IDE) to evaluate the safety and feasibility of the...

Absence of known cardiovascular risk factors increases risk of sudden cardiac...

Data from the e-MUST study show that the absence of known cardiovascular risk factors is an independent risk factor for sudden cardiac arrest prior...

TAVI-induced bundle branch block and permanent pacemaker implantation are “not benign”

New data indicate that patients who develop bundle branch block (BBB) and/or require a new permanent pacemaker after undergoing transcatheter aortic valve implantation (TAVI)...

Increased BMI associated with significant increase in radiation exposure to physicians

Ryan D Madder (Frederik Meijer Heart and Vascular Institute, Spectrum Health, Grand Rapids, USA) and others write in Circulation: Cardiovascular Interventions that increased body...

Meta-analysis shows FFR-guided PCI reduces myocardial infarction

A meta-analysis of individual patient-level data from FAME 2, DANAMI-PRIMULTI and Compare-Acute indicates that percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR)...

More work needed to “untangle reasons” for gender gap in cardiovascular...

Writing in Circulation: Cardiovascular Quality and Outcomes, David Ouyang (Stanford University, Falk Research Center, Palo Alto, USA) and others report that while the number...

The SYNTAX score should not be used to choose between CABG...

A post-hoc analysis of FREEDOM (Future revascularisation evaluation in patients with diabetes mellitus: optimal management of multivessel disease) indicates that coronary artery bypass grafting...

BioCardia submits 510(k) application to US FDA for its Avance steerable...

BioCardia has announced its 510(k) submission for US FDA clearance of the Avance steerable introducer, which is designed for introducing various cardiovascular catheters into...

Merit releases Prelude IDeal hydrophilic sheath

Merit Medical has announced the release of the Prelude IDeal hydrophilic sheath Introducer in European, Middle Eastern and African Markets. A press releases reports...

US District Court for the District of Delaware rules that Sapien...

A jury in the US District Court for the District of Delaware determined that the Boston Scientific US patent 8,992,608 is valid and that...

Abiomed invests $15 million in Shockwave Medical

A press release reports that Abiomed is to invest US$15 million in Shockwave Medical and the two companies will collaborate on a training and...

Edwards Lifesciences to collaborate with Bay Labs to use AI software...

Edwards Lifesciences is to work with Bay Labs on improving the detection of heart disease. The partnership involves multiple initiatives, including the development of...

Women wait for longer before calling for help when experiencing heart...

Woman patient
Matthias Meyer (Triemli Hospital, Zurich, Switzerland) and others report in European Heart Journal: Acute Cardiovascular Care women who are experiencing symptoms of a myocardial...

First-in-human “remote PCI” performed

CorPath technology has been successfully used in the first-in-human telerobotic intervention study in India; the study is assessing the efficacy and safety of conducting...

HeartFlow initiates PRECISE randomised clinical trial

HeartFlow has announced the start of the PRECISE (Prospective randomised trial of the optimal evaluation of cardiac symptoms and revascularisation trial). The first patient...

Draft NICE guidance supports use of percutaneous mitral valve repair

In draft recommendations, England’s National Institute for Health and Care Excellence (NICE) gives the go-ahead for percutaneous edge-to-edge repair (MitraClip, Abbott) for mitral regurgitation...

In some cases, we are not doing PCI in the right...

 “The real question is: who should get percutaneous coronary intervention (PCI)? I do not believe that we are doing too many PCIs but in...

The first 60 years of cardiac pacing

Sixty years ago, the first pacemaker implant was made in Stockholm, Sweden (Senning & Elmqvist) on 8 October 1958. The patient had atrioventricular block...

Fantom bioresorbable scaffold implanted for the first time in Italy

Reva Medical announced the first implant of its recently launched Fantom Encore bioresorbable scaffold in Italy. The implant procedure was performed by Antonio Colombo...

First implant of Pascal transcatheter mitral valve repair device performed in...

The first implant of the Pascal mitral valve repair device (Edwards Lifesciences) in the CLASP IID pivotal trial has been performed at the Atlantic...

TAVI-proof procedures and device designs

Transcatheter aortic valve implantation (TAVI) is now a well-established treatment for aortic stenosis and is approved as an alternative to surgical aortic valve replacement...

JenaValve receives FDA approval for expanded IDE enrolment in the treatment...

JenaValve has received US FDA approval of expansion of its investigational device exemption (IDE) feasibility studies for the JenaValve pericardial transcatheter aortic valve implantation...

Personalised ultrasound scan showing atherosclerosis helps reduce cardiovascular risk

Ulf Näslund (Umeå University, Umeå, Sweden) and others report in The Lancet that sharing pictorial representations of personalised scans that show the extent of...

Quidel receives CE mark for its TriageTrue high sensitivity troponin I...

Quidel has received the CE mark for its TriageTrue high sensitivity troponin I test for the quantitative determination of troponin I in EDTA anticoagulated...

WeHealth by Servier and MobioSense form a partnership to develop digital...

WeHealth by Servier, Servier Group’s e-health Business unit, and MobioSense, a leading semiconductor biosensor platform developer based in Taiwan and Boston, announced the closing...

American College of Cardiology New York Cardiovascular Symposium to bring together...

The American College of Cardiology New York Cardiovascular Symposium will be held 7–9 December midtown Manhattan (New York, USA) to provide clinicians with in-depth...

Presence of left bundle branch block significantly increases risk of pacemaker...

Quentin Fischer (Department of Cardiology, Quebec Heart and Lung Institute, Laval University, Quebec City, Canada) and others report in Circulation: Cardiovascular Interventions that patients...

Orsiro may be the new benchmark for comparison in drug-eluting stent...

At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21–25 September, San Diego, USA), David Kandzari (Piedmont Heart Institute, Atlanta, USA) presented the two-year results...

BASILICA: A new approach for preventing coronary obstruction in TAVI

Insufficient blood flow towards the coronary vasculature following transcatheter aortic valve implantation (TAVI) is a dreadful complication. This can result in a wide spectrum...

US FDA plan shakeup of its 510(k) clearance programme

The US FDA has announced plans to modernise its 510(k) clearance programme for approving medical devices for the US market. Data show that about...

The resurgence of renal denervation

More than ever before, arterial hypertension represents one of the greatest health threats and challenges for both patients and treating physicians. With the new...

EACTS 2018: From bench to bedside: Roundtrip for cell therapy in...

The study of stem cells in regenerative medicine is a growing field of basic and clinical research, generating a broad interest and debate in...

AHA 2018: Efficacy and safety of PCI with Ti-no coated bio-active...

The results of the meta-analysis pooling all existing randomised controlled trials comparing Ti-no coated bio-active stents (such as Optimax, Hexacath) and drug-eluting stents were...

Pulmonary artery denervation: A novel approach to managing pulmonary hypertension

According to the results of PADN-5, pulmonary artery denervation (PADN) is associated with significant improvements in haemodynamic and clinical outcomes in patients with post-capillary...

Frail, older patients have 50% increased risk of bleeding during hospitalisation...

John A Dodson (New York University School of Medicine, New York, USA) and others report in JACC: Cardiovascular Interventions that patients over age 65...

Launch of Sapien 3 Ultra hampered by Boston Scientific dispute

The CE mark has been granted to the Sapien 3 Ultra (Edwards Lifesciences) transcatheter aortic valve implantation (TAVI) device, but a dispute between Edwards...

Bay Labs and Northwestern Medicine enrol first patient in study using...

Bay Labs and Northwestern Medicine have announced that the first patient has been enrolled in a first-of-its-kind study. The study will evaluate the use...

HeartFlow receives national reimbursement approval in Japan

The Japanese Ministry of Health, Labor and Welfare (MHLW) has approved the recommendation by the Central Social Insurance Medical Council (Chuikyo) to provide reimbursement...

TCT 2018: Multivessel NIRS is feasible, safe and can predict future...

Ron Waksman The Lipid Rich Plaque (LRP) study indicates that cardiac patients with a high lipid core plaque burden index (LBCI), identified with...

AHA 2018: Early invasive strategy without pretreatment significantly reduces recurrent ischaemic...

Data from the EARLY randomised trial indicate that patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) who undergo a very early invasive strategy (<2...

AHA 2018: Pilot study paves way for future evaluation of delaying...

A pilot study comparing a strategy of left ventricular unloading with the Impella CP device (Abiomed) and delayed reperfusion (up to 30 minutes after...

AHA 2018: REGROUP trial

In this video from the European Society of Cardiology, Roxana Mehran (Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount...

US FDA approve new study of Medtronic’s Spyral renal denervation system

The FDA have given Medtronic approval to begin a clinical trial to evaluate the Symplicity Spyral renal denervation system in patients with hypertension who...

Vivasure Medical announces launch of the PerQseal large bore closure device

Vivasure Medical has announced the European launch of the PerQseal closure device for large-bore transcatheter procedures, including transcatheter aortic valve implantation (TAVI), thoracic endovascular...

NeoChord announces US$25 Million Series D financing to accelerate development of...

NeoChord has announced that it has completed a US$25 million Series D equity financing. Proceeds from the financing will be used to accelerate the...

AHA 2018: Study shows AliveCor phone app can effectively identify STEMI...

An international study, led by researchers from the Intermountain Medical Center Heart Institute in Salt Lake City, found that a smartphone app (AliveCor) to...

First patient in Hong Kong receive treatment with coronary Orbital Atherectomy...

The first patient in Hong Kong has been treated with the Diamondback 360 coronary Orbital Atherectomy System (Cardiovascular Systems). A press release reports that...

Mark Schwartz become vice president of Clinical Affairs at BioCardia

BioCardia has announced that Mark Schwartz—a 25-year veteran of cardiovascular device development—has joined the company as Vice President of Clinical Affairs. A press release...

TCT 2018: Sham-controlled trial indicates indirect annuloplasty reduces mitral regurgitation

REDUCE-FMR indicates that indirect annuloplasty with the Carillon device (Cardiac Dimensions) is associated with a significant reduction in mitral regurgitation in patients with secondary...

Cordis launches Mynx Control vascular closure device in the USA

Cordis, a Cardinal Health company, has launched its Mynx Control vascular closure device onto the US market. A press release reports that the Mynx...

Fantom Encore launched onto market

Reva Medical announced the commercial launch of the Fantom Encore bioresorbable scaffold and the first implant of the device in the FANTOM Post Market...

First US implantations of TriCinch Coil tricuspid valve repair system performed

4TECH has initiated its US early feasibility study, following receipt of approval from the US FDA, with the successful first two implantations of the...

Colder air and reduced sunshine increases risk of myocardial infarction

A new study indicates that low air temperature, low atmospheric air pressure, high-wind velocity, and shorter sunshine duration are associated with an increased risk...

Atrial fibrillation related to PFO closure occurs early and is transient

A new meta-analysis of patients undergoing percutaneous closure of patent foramen ovale (PFO) after cryptogenic shock supports previous studies that indicate PFO closure is...

New drug formulation could help people undergoing heart surgery

According to a press release, Raimondo Ascione, Saadeh Suleiman (Bristol Heart Institute, University of Bristol, Bristol, UK) and colleagues are to develop and test...

BioCardia and CellProThera to partner for clinical trial and marketing in...

CellProThera and BioCardia announced an agreement to expand their current collaboration to the SIngXpand clinical trial in Singapore. The study will evaluate the safety...

TCT 2018: Durable tricuspid regurgitation reduction with MitraClip

Data from the TriValve Registry—an international multicentre, retrospective, multidevice, registry evaluating interventional tricuspid repair—indicates that interventional edge-to-edge repair (MitraClip, Abbott) to manage patients with...

TCT 2018: Severe prosthesis-patient mismatch linked to increased mortality at one...

The largest study to date of prosthesis-patient mismatch following transcatheter aortic valve implantation (TAVI) shows that severe mismatch is associated with a significantly higher...

iVascular acquires 10% of NaviGate Cardiac Structures for US$10 million

The collaboration agreement between iVascular and NaviGate Cardiac Structures (NCSI) has been formalised, meaning iVascular has acquired 10% of shares of NCSI for US$10...

US FDA approve HeartMate 3 heart pump for advanced heart failure...

The HeartMate 3 left ventricular assist device has received US FDA approval as a destination therapy for people living with advanced heart failure. With...

Single-use, high-definition, miniature camera unveiled at Asia Pacific MedTech Forum 2018

At Asia Pacific MedTech Forum 2018 (9-10 October, Singapore), Cambridge Consultants demonstrated its single-use, high-definition miniature camera. Called “Leap”, according to a press release,...

First patient enrolled in STTAR study of MIA—minimally invasive annuloplasty

Micro Interventional Devices announced the world's first percutaneous implantation of its MIA, minimally invasive annuloplasty, technology for tricuspid and mitral repair.  This marks the...

Caristo Diagnostics launched to commercialise new coronary CT image analysis technology

Caristo Diagnostics, an Oxford University spinout company, has been launched to commercialise a new coronary CT image analysis technology that can identify patients at...

Rivaroxaban gets FDA approval for treatment in CAD or PAD

Rivaroxaban, brand name Xarelto (Janssen), has received approval by the US Food and Drug Administration (FDA) to reduce the risk of major cardiovascular (CV)...

TMVI with Tiara valve may be safe and feasible for patients...

A new study indicates that transcatheter mitral valve implantation (TMVI) with the Tiara valve (Neovasc) can be safely and successfully implanted in patients with...

Risk of death with unrecognised myocardial infarction equal to that with...

Tushar Acharya (National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, USA) and others report in JAMA Cardiology that within 10 years,...

FDA approve TSP Crosser transseptal access system

Transseptal Solutions has received FDA 510(k) clearance for its TSP Crosser transseptal access system. A press release reports that the system has a novel...

Teleflex buys vascular closure company Essential Medical

Teleflex has acquired Essential Medical, which has developed and commercialised the CE marked Manta vascular closure device—specifically designed for closure of large bore arteriotomies...

ADVERTORIAL: Tricuspid annular reduction using Edwards Cardioband (TM) Tricuspid Valve Reconstruction...

This content is only for readers outside of the USA First real-world case experience with the Cardioband Tricuspid System by Marcel Weber, Jan-Malte Sinning, Nikos...

US trial of Edwards’ self-expanding Centera valve begins

Edwards Lifesciences has commenced the US pivotal trial that will study its self-expanding Centera transcatheter aortic valve implantation (TAVI) device for severe, symptomatic aortic...

Only one third of patients in China receive cardiac rehabilitation

Research presented at the 29th Great Wall International Congress of Cardiology (GW-ICC) meeting (11–14 October, Beijing, China) shows that just one-third of patients in...

TCT 2018: IVUS-guided PCI reduces target vessel failure in all-comers population

Jun-jie Zhang (Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China) and others report in the Journal of American College of Cardiology...

Heart Research UK award £250,000 to researchers developing AI test for...

UK-based charity Heart Research UK has given a Novel and Emerging Technologies (NET) Grant of £250,00 to Jack Lee (King’s College London, London, UK)...

The US should follow Europe’s lead and change guidelines on embolic...

The revised European Society of Cardiology (ESC) myocardial revascularisation guidelines have downgraded the use of embolic protection devices during saphenous vein graft intervention from...

ADVERTORIAL: Unique design and features of the ACURATE neo (TM) enable...

This content is only for readers outside of the US as it discusses a device that is not FDA approved. Results from the SAVI-TF Registry1,...

Olaf Wendler

Olaf Wendler (lead for Cardiothoracic Surgery, King’s Health Partners, and chair of the Heart and Vascular Institute of the Cleveland Clinic London, UK) performed...

Venus Medtech to buy cerebral protection device company Keystone Heart

Venus Medtech has signed an agreement to acquire Keystone Heart, a privately-held medical device company and makers of TriGUARD 3—a cerebral embolic protection device...

Megha Prasad selected as SCAI-Women in Innovations CHIP Fellowship

The Society for Cardiovascular Angiography and Interventions (SCAI) has announced that Megha Prasad has been selected as the recipient of the SCAI-Women in Innovations...

TCT 2018: Orsiro continues to have lower rates of target lesion...

Two-year data from the BIOFLOW-V randomised trial—which compared a sirolimus stent with a biodegradable polymer (Orsiro, Biotronik) with a everoliums-eluting stent with a permanent...

TCT 2018: One-year real-world results show Portico TAVI system reduces severe...

According to one-year results from the PORTICO I study, which were presented during a late-breaking session at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting...

TCT 2018: Longest-term data to date for CoreValve study show excellent...

New data presented at 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21–25 September, San Diego, USA), according to a press release, patients implanted with the...

TCT 2018: Use of Impella in cardiogenic shock patients associated with...

A new analysis of data from the Impella (Abiomed) Quality (IQ) Database shows a relative increase of 24% in mean survival in acute myocardial...

TCT 2018: LEADERS FREE II confirm favourable results for BioFreedom

The primary endpoint results of the LEADERS FREE II trial were presented at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21–25 September, San Diego,...

TCT 2018: Restore drug-coated balloon matches Resolute for small vessel lesions

Data presented at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21–25 September, San Diego, USA) indicates that the performance of Restore (Cardionovum) matches that...

TCT 2018: FFRangio may provide a faster and easier approach to...

The FAST-FFR trial, which was presented at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21–25 September, San Diego, USA) and published in Circulation, indicate...

TCT 2018: Audience claps as COAPT shows MitraClip reduces HF hospitalisations

Delegates at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21-25 September, San Diego, USA) broke into spontaneous applause after Gregg Stone (Columbia University Medical...

TCT 2018: Lower rate of stent thrombosis with Resolute Onyx vs....

Data presented yesterday at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21-25 September, San Diego, USA) indicate that there were no significant differences in...

Cardiovascular News Issue 51—September 2018 US edition

In our latest issue, we report on the top stories from the 2018 ESC Congress—including MITRAL.FR, CULPRIT-SHOCK (one-year data), and Low Risk TAVR. We...

Cardiovascular News Issue 51—September 2018

In our latest issue, we report on the top stories from the 2018 ESC Congress—including MITRAL.FR, CULPRIT-SHOCK (one-year data), and Low Risk TAVR. We...

US FDA approve study of CoreValve Evolut in low-risk patients with...

The US FDA has approved an investigational device exemption (IDE) to initiate a single-arm study to evaluate the CoreValve Evolut transcatheter aortic valve implantation...

First patient enrolled in CARILLON pivotal trial

Cardiac Dimensions has announced the company has randomised its first patient in the CARILLON pivotal trial, which is evaluating the Carillon mitral contour system...

PCR LV 2018: One-year results of VIVA confirm safety and efficacy...

Speaking at PCR London Valves (9–11 September, London, UK) Didier Tchétché (Clinique Pasteur, Toulouse, France) reported that the one-year results of the VIVA (valve-in-valve)...

PCR LV 2018: Early discharge feasible for unselected TAVI patients

Data from the multicentre FAST-TAVI trial indicate that early discharge—discharge within 72 hours—in an all-comers population undergoing transcatheter aortic valve implantation (TAVI) is safe...

PCR LV 2018: Favourable outcomes for next-generation Acurate neo2 TAVI system

A new study evaluating the safety and performance of the Acurate neo2 (Boston Scientific) transcatheter aortic valve implantation (TAVI) system demonstrated a high procedural...

Onyx One Clear study starts in USA and Japan

Medtronic has announced the start of the Onyx ONE Clear Study in the USA and Japan that will evaluate one-month dual antiplatelet therapy (DAPT)...

US FDA approves PK Papyrus stent for coronary perforations

The US FDA has approved the PK Papyrus covered coronary stent system (Biotronik) under Humanitarian Device Exemption for use in the emergency treatment of...

Two patients have been implanted with latest-generation of integrated ICE delivery...

Two patients have been successfully treated with Millipede’s latest-generation delivery system that incorporates a fully integrated intracardiac echocardiography (ICE) catheter. The catheter was designed...

TCT 2018: Infraredx to present results of the LRP study

Results from the highly anticipated LRP (Lipid-Rich Plaque) study will be presented during a late-breaking clinical trial session at the 2018 Transcatheter Cardiovascular Therapeutics...

TCT 2018: Corindus to feature the CorPath GRX system at...

Corindus Vascular Robotics is to feature its CorPath GRX system at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21–25 September, San Diego, USA). The...

SCAI mourns past president Joseph D Babb

The Society for Cardiovascular Angiography and Interventions (SCAI) has announced the death of Joseph D Babb, who was president of SCAI from 2001 to...

BTG buys Novate Medical

BTG has announced it has acquired Novate Medical (“Novate”), a medical device company focused on the prevention of pulmonary embolism in patients at high...

Gore buys transcatheter mitral chordal repair technology

Gore has acquired Pipeline Medical Technologies—a privately held medical technology company focused on advancing chordal repair for degenerative mitral regurgitation via a transcatheter procedure....

First patients enrolled in trial of MobiusHD for drug-resistant hypertension

Vascular Dynamics has revealed that enrolment of the first patients in an FDA-approved and best-in-class pivotal clinical trial has started. The CALM-2 study is...

ESC 2018: TMVI associated with “excellent outcomes” for valve-in-valve procedures

New results from the TMVR (Transcatheter mitral valve replacement) Registry show that patients with a degenerated bioprosthesis who undergo transcatheter mitral valve implantation (TMVI)...

SIS Medical to launch three innovative balloon catheters

SIS Medical is to launch three new models of its balloon catheters—EasyT, NIC 1.1 hydro and NIC Nano hydro—and say all three have characteristics...

The number of metallic layers affects efficacy of drug-coated balloons for...

Hiroto Yabushita and colleagues report in Circulation: Cardiovascular Interventions that drug-coated balloon treatment of in-stent restenosis lesions with three or more metallic layers results...

ESC 2018: More evidence that FFRCT is an effective approach for...

Bjarne L Nørgaard (Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark) and colleagues report in the Journal of the American College of Cardiology (JACC)...

Patients with new-onset atrial fibrillation after TAVI have highest risk of...

Amit N Vora (Duke University Medical Center/the Duke Clinical Research Institute, Durham, USA) and others report in in JACC: Cardiovascular Interventions that patients who...

ESC 2018: First US FDA-approved study shows TAVI is safe for...

The LRT (Low Risk TAVR) trial did not find any significant differences in the rate of all-cause mortality between low-risk patients undergoing transcatheter aortic...

ESC 2018: Novel imaging biomarker can predict risk of cardiac mortality

Milind Desai (Cleveland Clinic, Cleveland, USA) and colleagues have identified a novel imaging biomarker that has been found to be able to predict all-cause...

ESC 2018: Positive one-year results for Interatrial Shunt Device

One-year follow-up data from the REDUCE LAP-HF I clinical study of the Interatrial Shunt Device (IASD, Corvia Medical) demonstrate shunt patency (blood flow from...

ESC 2018: All-cause mortality in cardiogenic shock multivessel PCI only increased...

One-year data from the CULPRIT-SHOCK trial indicate that there is no significant difference in all-cause mortality between cardiogenic shock patients undergoing immediate multivessel percutaneous...

ESC 2018: Ticagrelor monotherapy approach does not challenge current DAPT approach

The GLOBAL LEADERS trial, simultaneously published in the Lancet and presented at the 2018 European Society of Cardiology (ESC) Congress (25–29 August, Munich, Germany),...

ESC 2018: No difference in MACE between drug-coated balloons and drug-eluting...

The 12-months results of the BASKET-SMALL 2 study, which were presented at the 2018 European Society of Cardiology (ESC) Congress (25–29 August, Munich, Germany),...

ESC 2018: Higher all-cause mortality with Orsiro at five years than...

According to the five-year results of the BIOSCIENCE trial, sirolimus-eluting stents with a biodegradable polymer (Orsiro, Biotronik) have a similar overall safety and efficacy...

ADVERTORIAL: Rethinking the future of cardiology imaging

This content is only for readers outside of the USA In an environment with growing demand for specialist cardiology services, it is important that health...

ESC 2018: MitraClip makes “absolutely no difference” for the prognosis...

The first randomised controlled trial to compare percutaneous edge-to-edge repair (MitraClip, Abbott) with medical therapy alone in patients with secondary mitral regurgitation (to heart...

Revising the National Coverage Determination for TAVI: The real barrier to...

Recently the Centers for Medicare and Medicaid Services (CMS) reopened the National Coverage Determination (NCD) for transcatheter aortic valve implantation (TAVI). Much of the...

ESC 2018: Greater use of PCI for high SYNTAX score patients...

The final results of the FUTURE (Functional testing underlying revascularisation) trial indicate that more patients with multivessel disease and a high SYNTAX score (>32)...

Simultaneous TAVI and left atrial appendage closure is feasible

Thomas S Gilhofer (University Heart Center, Department of Cardiology, University Hospital Zurich, Zurich, Switzerland) and others report in Structural Heart that a combined procedure...

ESC 2018: DAPT score “not generalisable” to a nationwide population

A new study has found that the dual antiplatelet therapy (DAPT) score, which is recommended by both US and European guidelines, did not adequately...

ESC 2018: Non-atherosclerotic spontaneous coronary artery dissection predominantly affects young to...

Data from the Canadian Spontaneous Coronary Artery Disease (CanSCAD) study indicate that the majority of patients with non-atherosclerotic spontaneous coronary artery dissection are young...

ESC 2018: British Heart Foundation to provide £30m for innovation in...

At the 2018 European Society of Cardiology (ESC) Congress (25–29 August, Munich, Germany), British Heart Foundation (BHF) announced the “Big Beat Challenge”—an £30m award...

Cerner and Duke Clinical Research Institute collaborate on new app for...

Cerner has collaborated with Duke Clinical Research Institute to develop the atherosclerotic cardiovascular disease (ASCVD) Risk Calculator app, which is designed as a tool...

ESC 2018: Siemens Healthineers showcase Magnetom Sola Cardiovascular Edition

At the 2018 European Society of Cardiology (ESC) Congress (25–29 August, Munich, Germany), Siemens Healthineers launched Magnetom Sola Cardiovascular Edition—a 1.5 Tesla magnetic resonance...

ESC 2018: Cardioskin launched

WeHealth, by Servier, has launched Cardioskin—a connected solution that is designed to function as an ambulatory wearable 15-lead ECG—at the 2018 European Society of...

Bayer announces new licensed indication for use of Xarelto in patients...

Xarelto, co-administered with aspirin, is indicated in the EU for the prevention of atherothrombotic events in adult patients with coronary artery disease at high...

Twenty thousand patients have now been treated with RenalGuard therapy

RenalGuard Solutions has announced the treatment of 20,000 patients with RenalGuard for the prevention of contrast-induced nephropathy. A press release reports that the system,...

More than 100,000 people now know hands-only CPR thanks to AHA...

More than 100,000 people have been trained in hands-only cardiopulmonary resuscitation (CPR) since the American Heart Association (AHA) launched its hands-only CPR training kiosk...

Juan F Granada

Juan F Granada (president and CEO, Cardiovascular Research Foundation, New York, USA) wanted to be a physician from a young age and fell in love...

ClearFlow awarded group purchasing agreement for the chest drainage products category...

ClearFlow has been awarded a group purchasing agreement—chest drainage contract: Contract # PP-OR-1561—for the chest drainage products category with Premier. A press release reports...

Philips launches new cardiac ultrasound solutions with anatomical intelligence

Philips has introduced the EPIQ CVx cardiovascular ultrasound system. Built on the EPIQ ultrasound platform, EPIQ CVx is specifically designed to increase diagnostic confidence...

Cardiovascular News Issue 50—August 2018 US edition

In this edition (Issue 50), we report on the key studies from EuroPCR 2018—SPYRAl HTN-ON, ORBITA FFR/iFR analysis, and FAME (five-year results). We also...

Cardiovascular News Issue 50—August 2018

In this edition (Issue 50), we report on the key studies from EuroPCR 2018—SPYRAl HTN-ON, ORBITA FFR/iFR analysis, and FAME (five-year results). We also...

ADVERTORIAL: Edwards’ CardiobandTM Tricuspid Valve Reconstruction System: A new option for...

This content is only for readers outside of the US as it discusses a device that is not FDA approved. The granting of the CE...

The risks and benefits of exercise after a myocardial infarction

In a new position paper, published in the European Heart Journal, the Sports Cardiology Section of the European Association of Preventive Cardiology (EAPC) outline...

Novel Ultraseal device is a feasible option for left atrial appendage...

A feasibility study of a novel left atrial appendage device (Ultraseal, Cardia) indicates that the device is associated with a high rate of procedural...

Three-quarters of patients have sustained results at very long-term follow-up after...

Rafael A Meneguz-Moreno (Department of Interventional Cardiology, Instituto Dante Pazzanese De Cardiologia, Sao Paulo, Brazil) and others report on JACC: Cardiovascular Interventions that after...

“No option” for revascularisation in refractory angina does not mean never

Data from OPTIMIST (Options in myocardial ischemic syndrome therapy) registry indicate that a quarter (25%) of patients with refractory angina who are initially deemed...

FDA sends letter warning about mortality and risks with the Syncardia...

The US FDA has sent a letter to transplant surgeons and cardiologists about the Syncardia temporary Total Artificial Heart (TAH-t) Companion 2 Driver. The...

Enrolment in FAST-FFR trial completed early

CathWorks has announced that its FAST-FFR trial is fully enrolled ahead of schedule. The trial is designed to evaluate efficacy of the CathWorks FFRangio...

Chronic kidney disease should not be a barrier to TAVI

The first study to compare the use of transcatheter aortic valve implantation (TAVI) with conservative management in patients with chronic kidney disease (3–5) indicates...

Re-evaluate use of anticoagulation in patients with atrial flutter

A new study, published in JAMA Network Open, indicates that patients with atrial flutter have a lower incidence of stroke than patients with atrial...

“Communication is key” when managing patients who seek discharge against medical...

Chun Shing Kwok (Keele Cardiovascular Research Group, Keele University, Stroke-on-Trent, UK) and others report in JACC: Cardiovascular Interventions that only 0.5% of percutaneous coronary...

Increased rate of acute myocardial infarction during pregnancy linked to increase...

A new study published in Mayo Clinical Proceedings indicates that the rate of acute myocardial infarction among pregnant women increased between 2002–2003 and 2012–2013...

Female acute myocardial infarction patients experience worse outcomes when treated by...

Brad N Greenwood (Carlson School of Management, University of Minnesota-Twin Cities, Minneapolis, USA) and others report in Proceedings of the National Academy Sciences of...

“Tricuspidisation” could be a potential approach to performing TAVI in certain...

At present, a bicuspid aortic valve is seen as a relative contradiction for transcatheter aortic valve implantation (TAVI) and, thus, surgical aortic valve replacement...

Patient enrolment in US early feasibility study of Everdur TAVI device...

JenaValve has announced initiation of patient enrolment in its early feasibility study (EFS) of its next-generation JenaValve pericardial transcatheter aortic valve implantation (TAVI) system...

PRECLUDE study of Caisson TMVI system concludes

LivaNova has announced the conclusion of the PRELUDE feasibility study for its Caisson transcatheter mitral valve implantation (TMVI) system. The PRELUDE first-in-human study evaluated...

Safety and efficacy results of REDUCE study published in International Journal...

The manuscript “Safety and efficacy of the Reducer: A multicentre clinical registry—REDUCE study” has been published in the International Journal of Cardiology. In this...

Boston Scientific closes acquisition of Claret Medical

Boston Scientific has announced that it has recently closed its acquisition of Claret Medical, which developed and commercialised the Sentinel cerebral embolic protection system—the...

New research links even low levels of air pollution with serious...

Researchers have found that people exposed to air pollution levels well within UK guidelines have changes in the structure of the heart, similar to...

VisONE system for heart failure implanted for first time

VisCardia has announced the first implant of its VisONE implantable system for heart failure, and the commencement of its VisONE Heart Failure pilot study...

CE mark and US FDA approval for RadialSeal introducer kit

Integer Holdings has received US FDA and CE mark approval for its new radial access introducer, RadialSeal. According to a press release, the RadialSeal...

Infraredx launches Makoto intravascular imaging system and Dualpro IVUS+NIRS catheter in...

Infraredx has announced the Makoto intravascular imaging system, and accompanying Dualpro intravascular ultrasound and near-infrared spectroscopy (IVUS+NIRS) catheter, is now available in Japan. The...

US FDA approval for SynchroMed II implantable system for treating pulmonary...

Medtronic has received US FDA approval for its implantable system for Remodulin to treat patients with pulmonary arterial hypertension. Through a first-of-its-kind collaboration, a...

Bayer receives positive CHMP opinion for rivaroxaban for patients with coronary...

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for a new indication...

Invasive strategy provides better outcomes for very elderly patients with NSTEACS

A study in EuroIntervention indicates that very elderly patients—mean age 84.3 years—with non-ST-segment elevation acute coronary syndromes (NSTEACS) who undergo invasive therapy have a...

Marital status may influence risk of cardiovascular outcomes after myocardial infarction

Chun Wai Wong (Cardiovascular Research Group, Keele University, Stroke-on-Trent, UK) and others report in Heart that, following a myocardial infarction, single people have a...

On the fence result for initial CMS vote about TAVI volume...

A Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) panel of the Centers for Medicare & Medicaid Services (CMS), according to Medscape, has not...

Abbott launches trial of its Tendyne transcatheter mitral valve implantation device

Abbott has initiated a pivotal clinical study in the USA of its Tendyne transcatheter mitral valve implantation (TMVI) system for the treatment of mitral...

Siemens Healthineers transforms care delivery with innovative new tests for faster...

Siemens Healthineers has announced it is helping to shorten the time doctors can diagnose a life-threatening myocardial infarction with the introduction of two assays...

Benefit of epinephrine in out-of-hospital cardiac arrest countered by its neurologic...

Data from PARAMEDIC2 (Prehospital assessment of the role of adrenaline: Measuring the effectiveness of drug administration in cardiac arrest) indicate that epinephrine in adults...

Nitroglycerin may be a safe, effective, and economic approach of reducing...

Yequn Chen (Department of Cardiology, First Affiliated Hospital of Shatou University Medical College, China) and others report in Circulation: Cardiovascular Interventions that subcutaneous injection...

“Remote PCI” successfully performed 100 miles away from the cath lab

Corindus Vascular Robotics has announced that Ryan Madder (Spectrum Health, Ludington, USA) has successfully completed a remote percutaneous coronary intervention (PCI) in a porcine...

Advance CS coronary sinus infusion catheter used for the first time

Cook Regentec has announced the first clinical use in the USA of the Advance CS coronary sinus infusion catheter and CompassCT disposable pressure transducer...

Boston Scientific to buy cerebral protection system company

Boston Scientific has signed an agreement to acquire Claret Medical, which developed and commercialised the Sentinel cerebral embolic protection system. The device is used...

Reva’s Fantom scaffold is now being distributed in Italy

Reva is expanding commercial access to the Fantom bioresorbable scaffold with a new distribution partnership in Italy. The company will work with Bio Vascular...

“Wait-and-see” is not an option with the new device regulations

The new EU Medical Device Regulation (MDR) was officially published on 5 May 2017 and entered into force 20 days later, on 25 May...

Cardiovascular Systems signs international distribution agreement with OrbusNeich

Cardiovascular Systems, Inc. (CSI) has signed an exclusive international distribution agreement with OrbusNeich to sell its coronary and peripheral orbital atherectomy systems (OAS) outside...

Societies launch joint report on TAVI

The 2018 American Association for Thoracic Surgery (AATS), the American College of Cardiology (ACC), the Society for Cardiovascular Angiography and Interventions (SCAI), and the...

Creavo launches largest US study of its kind

A new cardiac diagnostic device (Vitalscan) aimed at helping physicians rule out active ischaemia in patients presenting to the emergency department with chest pain...

US FDA clearance for TEECAD system for aiding transoesophageal echocardiography

Visura Technologies has received 510(k) clearance from the US FDA for its transoesophageal echocardiography (TOE) Camera Assist Device (TEECAD) system. A press release reports...

MedShr: A physician-designed online platform for case discussion

MedShr, which now has more than 500,000 physician users in 180 countries, is an online platform that combines social media technology with a network...

Leaflex Performer: A non-implant based treatment for aortic stenosis

Given sufficient time, all bioprosthetic valves fail—whether they are surgical or transcatheter devices. The most important predictive factor for bioprosthetic heart valve degeneration is...

Next-generation of MitraClip approved for use in the USA

Abbott has received approval from the US FDA for a next-generation version of its MitraClip heart valve repair device used to reduce mitral regurgitation....

Consider the transaortic approach when faced with difficult iliofemoral anatomy

The first propensity-matched comparison between the transaortic approach and the transfemoral approach in patients undergoing transcatheter aortic valve implantation (TAVI) at a high-volume centre...

Malnourished patients have a three-fold risk of mortality after aortic valve...

New data from the FRAILTY-AVR study indicate that mortality—both at 30 days and at one year—is significantly increased in malnourished patients undergoing aortic valve...

Funding for Neptune left ventricular assist device

A press release reports that the CALYPSO programme will receive 14 million euros to develop CorWave Neptune—a new type of cardiac support designed to...

CPT code for CathWorks’ 3D FFRangio wire free system

CathWorks has received a new CPT code 0523T for its non-invasive, 3D FFRangio system, which is designed to assess atherosclerotic stenoses during coronary angiography...

Otsuka Medical Devices, Otsuak Holdings, and ReCor Medical to merge

Otsuka Holdings, Otsuka Medical Devices, and ReCor Medical have signed a merger agreement pursuant to which Otsuka Holdings will acquire the remaining shares in...

New way to regenerate hearts after myocardial infarction identified

Researchers funded by the British Heart Foundation have identified how a new treatment in mice can regenerate the heart after a myocardial infarction—preventing the...

ADVERTORIAL: Edwards Cardioband™ Mitral Valve Reconstruction System—Reliably addressing annular dilatation

This content is only for readers outside of the US as it discusses a device that is not FDA approved. In recent years, several transcatheter...

The “absolute priority” is to develop onco-cardiology guidelines to help clinicians

In a “Call to action”, published in the Journal of American College of Cardiology, Tochi M Okwuosa (Division of Cardiology, Rush University Medical Center,...

TVT 2018: New-generation TAVI devices perform well in patients with large...

A new study indicates that transcatheter aortic valve implantation (TAVI) with a new-generation device—CoreValve Evolut R (Medtronic) or Sapien 3 (Edwards Lifesciences)—can be used...

HeartWare HVAD system receives US FDA approval

Medtronic has received United States Food and Drug Administration (FDA) approval for a less-invasive implant approach of its HVAD System, a left ventricular assist...

Cardiac Myosin-binding Protein C: Improving chest pain triage by using a...

The diagnosis of acute myocardial infarction and, therefore, chest pain triage has become increasingly complicated. Cardiac troponins (cTn) have emerged as the gold standard...

Leaflet thrombosis is not a predictor of stroke or all-cause mortality...

The largest study to date to systematically review outcomes associated with leaflet thrombosis after transcatheter aortic valve implantation (TAVI) indicates that the presence of...

Corwave announces issuance of US Patent Covering its implantable left ventricular...

CorWave has announced that it has obtained patent no. US 9,968,720 B2 on May 15, 2018 from the US Patent and Trademark Office. Titled...

Cardiac hybrid imaging is an effective tool for predicting myocardial infarction

According to a study published in Radiology, cardiac hybrid imaging with computed tomography (CT) and nuclear stress testing is an excellent long-term predictor of...

Endotronix joins AHA’s Center for Health Technology & Innovation to broaden...

Endotronix has announced they have joined the American Heart Association’s Center for Health Technology & Innovation’s (CHTI) Innovators Network. The collaboration allows Endotronix to...

Lexington Biosciences concludes initial HeartSentry clinical study

Lexington Biosciences has announced the completion of the initial HeartSentry study, conducted at San Francisco Bay-area Diablo Clinical Research (USA). As part of the...

Largest insurer in USA now covers HeartFlow Analysis

HeartFlow has announced that UnitedHealthcare now covers its HeartFlow FFRct Analysis system; UnitedHealthcare is the largest insurer in the USA and, therefore, the announcement...

AorTech sign development agreement with Vascular Flow Technologies

AorTech, a biomaterials and medical device IP company, has signed a development agreement with Vascular Flow Technologies for the development of its synthetic heart...

ACC’s ACTION registry to become Chest Pain—MI Registry

The American College of Cardiology’s (ACC) ACTION Registry is changing its name to the Chest Pain—MI Registry. A press release reports that the new...

TVT 2018: Tiara TMVI device featured in live case

Neovasc announced that its Tiara transcatheter mitral valve implantation (TMVI) device was featured in a live case that was broadcast at the 2018 Transcatheter...

Novel “smart stent” can tell physicians when restenosis is occurring

Kenichi Takahata (University of British Columbia, Vancouver, Canada) and colleagues have designed a “smart stent” that monitors even subtle changes in the flow of...

Third-generation drug-eluting stents and beyond: Where were we, where are we,...

Second-generation drug-eluting stents resolved the issues of late and very late stent thrombosis that were seen with the first-generation devices and have good safety...

Carotid disease is not a risk factor for stroke or death...

A new study, published in Circulation: Cardiovascular Interventions, shows that one fifth of patients undergoing transcatheter aortic valve implantation (TAVI) have evidence of carotid...

ADVERTORIAL: ACURATE neo: A “very safe” TAVI system providing “extremely good...

This content is only for readers outside of the US as it discusses a device that is not FDA approved. The ACURATE neo (Boston Scientific)...

TVT 2018: Positive results for Manta large bore closure device

Results from the SAFE MANTA IDE clinical trial—the first pivotal trial for a dedicated large bore closure device (Manta, Essential Medical)—show haemostasis was achieved...

One in five UK doctors say under staffing has affected patient...

The annual census of UK consultants and higher speciality trainees—Focus on Physicians 2017–18—indicates that more than half of all consultants and two thirds of...

Implantation of JenaValve successful in initial patients enrolled in CE mark...

JenaValve Technology has announced the initiation of patient enrolment and implantations associated with the CE mark study of its next-generation JenaValve pericardial transcatheter aortic...

Bisexual men have more risk factors for cardiovascular disease

According to a study published in LGBT Health, bisexual men have a higher risk for cardiovascular disease compared with heterosexual men across several modifiable...

Physicians are more willing to tolerate uncertainty about coronary artery disease...

Steven Farmer (Center for Healthcare Innovation and Policy Research, George Washington University, Washington, DC, USA) and others report in JAMA Cardiology that, following the...

Advantage of guided de-escalation of dual antiplatelet therapy seen in younger...

A pre-specified analysis of the TROPICAl-ACS study indicates that de-escalating dual antiplatelet therapy (DAPT), as guided by platelet function testing, after percutaneous coronary intervention...

First patient enrolled in phase II of REFLECT study of TriGuard...

Keystone Heart announced the launch of phase II of the REFLECT trial, which is evaluating the next-generation TriGuard 3 cerebral protection device. According to a...

Ron Waksman

Ron Waksman (MedStar Heart & Vascular Institute, Washington, DC, USA) is the course chairman of Cardiovascular Research Technologies (CRT; 3–6 March, Washington, DC, USA),...

US FDA approve EchoMD AutoEF software for calculating left ventricular ejection...

Bay Labs has received US FDA 510(k) clearance for its EchoMD AutoEF software product for the fully automated clip selection and calculation of left...

Caladrius receives FDA regenerative medicine advanced therapy designation for its CD34+...

Caladrius has revealed that the US FDA has granted regenerative medicine advanced therapy (RMAT) designation to its late-stage CD34+ cell therapy programme for the...

EuroPCR 2018: Study indicates “almost perfect agreement” between CT angiography and...

A new study, SYNTAX III REVOLUTION, has found heart teams using computed tomography (CT) angiography to decide between percutaneous coronary intervention (PCI) and coronary...

EuroPCR 2018: Both immediate and delayed approaches seem to work for...

A new study indicates that a delayed approach in patients with transient ST-segment elevation myocardial infarction (STEMI) is associated with similar safety and efficacy...

Combination of high-sensitive C-reactive protein with logistic EuroSCORE improves risk stratification...

According to Anja Stundl (Department of Medicine II, Heart Center Bonn, University Hospital, Bonn, Germany) and others, high-sensitive C-reactive protein (hs-CRP) can be used...

EuroPCR 2018: Will SPYRAL-ON change my practice?

In this PCR video, David E Kandzari (Department of Interventional Cardiology, Piedmont Heart Institute, Atlanta, USA) speaks to Atul Pathak (National Institute of Health and...

Consider patients’ risk of ischaemic stroke when choosing antiplatelet therapies after...

New data from ADAPT-DES, published in JACC: Cardiovascular Interventions, indicate that higher platelet reactivity units (PRU) is associated with an increased risk of ischaemic...

EuroPCR 2018: Low incidence of cardiovascular mortality with Centera self-expanding valve...

Hermann Reichenspurner (Departments of Cardiovascular Surgery and General and Interventional Cardiology, University Heart Center, Hamburg, Germany) at EuroPCR (22 May—25 May, Paris, France) reported...

Corindus receives Japanese PMDA approval for its CorPath GRX system

Corindus Vascular Robotics has received Pharmaceutical and Medical Device Agency (PMDA) approval for commercialisation of its CorPath GRX system in Japan. A press release...

EuroPCR 2018: No significant difference in bioprosthetic valve dysfunction between surgical...

The NOTION trial (Nordic aortic valve intervention) was the first comparison of surgical and transcatheter aortic valve implantation (TAVI) in patients at lower surgical...

EuroPCR 2018: Real-world data confirm trial outcomes for Sapien 3

Thirty-day data presented at EuroPCR (22 May—25 May, Paris, France) show consistently positive patient outcomes for patients undergoing transcatheter aortic valve implantation (TAVI) with...

Cardiology societies come together to provide key advice for dealing with...

The American College of Cardiology (ACC), Heart Rhythm Society (HRS), North American Society for Cardiovascular Imaging (NASCI), Society for Cardiovascular Angiography and Interventions (SCAI),...

EuroPCR 2018: FFR-guided PCI reduces spontaneous myocardial infarction

Five-year data from FAME (Fractional Flow Reserve vs. Angioplasty for Multivessel Evaluation) 2 show that patients with stable disease who undergo percutaneous coronary intervention...

Looks do matter—patients claim what doctors wear is important

According to a study published in BMJ Open, just over half of patients think what a doctor wears is important and more than a...

Cardiovascular News Issue 49—May 2018 US edition

For our May 2018 edition (Issue 49), we report on the key studies from the 2018 American College of Cardiology Scientific Session – including...

Cardiovascular News Issue 49—May 2018

For our May 2018 edition (Issue 49), we report on the key studies from the 2018 American College of Cardiology Scientific Session - including...

BCS 2018: Novel blood test for myocardial infarction could be used...

Data presented at the British Cardiovascular Society Conference (4–6 June, Manchester, UK) indicate that a novel blood test for diagnosing myocardial infarction could one...

Biomerics acquires FutureMatrix Interventional

Biomerics has bought FutureMatrix Interventional, which specialises in the design and manufacture of interventional catheters for the cardiovascular and urinary markets. A press release...

US FDA classifies HeartWare HVAD power issues as a Class I...

The US FDA has classified Medtronic’s recent voluntary urgent field action related to the HeartWare HVAD system’s unexpected power source switching as a Class...

EuroPCR 2018: New ORBITA analysis finds iFR/FFR values do not predict...

New data from the ORBITA trial indicates percutaneous coronary intervention (PCI) does not significantly reduce exercise time compared with a sham procedure in patients...

ADVERTORIAL: Sentinel Cerebral Protection System provides reassurance to both physicians and...

Compared with first-generation devices, new-generation transcatheter aortic valve implantation (TAVI) devices—along with iterative approaches in technique and imaging—have partially reduced the documented stroke rates...

EuroPCR 2018: Data confirms long-term safety and efficacy of Angiolite drug-eluting...

At EuroPCR (22 May–25 May, Paris, France), the 12-month results of the ANGIOLITE trial were presented for the first time by J Moreu Burgos....

EuroPCR 2018: PiCSO therapy reduces infarct size in acute myocardial infarction...

The clinical results from the OxAMI-PiCSO study—published in EuroIntervention and presented at EuroPCR (22 May–25 May, Paris, France)—provide further evidence for the use of the...

The European Commission authorise use of evolocumab to reduce risk of...

The European Commission (EC) has authorised a new indication in the evolocumab (Repatha, Amgen) label for adults with established atherosclerotic cardiovascular disease—myocardial infarction, stroke...

EuroPCR 2018: Interim nine-month results for Magnitude presented

Amaranth Medical provided an update on its sirolimus-eluting bioresorbable scaffold products during a satellite symposium at EuroPCR (22 May—25 May, Paris, France), including Magnitude...

Positive clinical results from eCOBRA study

CeloNova BioSciences has announced one-year clinical trial results from the eCOBRA post-market study of its Cobra PzF nano-coated stent. The clinical trial results demonstrated...

EuroPCR 2018: One- to two-year landmark analysis shows significantly lower target...

Two-year outcome data from the BIO-RESORT randomised controlled trial, which were presented in a late-breaking clinical trials session by Marlies M Kok (Thoraxcentrum Twente,...

EuroPCR 2018: Strong early vessel healing with Resolute Onyx in one-month...

Investigators unveiled clinical data from the independently run Onyx 1-Month OCT Study, which showed strong early vessel healing in a patient population that contained...

EuroPCR 2018: DIAB8 randomised study to compare Cre8 Evo with everolimus-eluting...

Alvimedica unveiled the details of the Diab8 study—the first diabetic drug-eluting stent randomised trial—during EuroPCR (22–25 May, Paris, France). Diab8 is a 55-centre, 3,040-patient...

ADVERTORIAL: Taking control of LDL-C when statin therapy is not enough

This content is for distribution within the UK only. This content is for distribution within the UK only. Currently, statins are the most common lipid-lowering therapy...

Xience Sierra approved for use in USA

Abbott has announced it has received approval from the US FDA for its Xience Sierra, the newest generation of the company’s gold-standard Xience everolimus-eluting...

EuroPCR 2018: Further evidence for safety and efficacy of Magmaris bioresorbable...

Data presented during EuroPCR (22 May – 25 May, Paris, France) provide further evidence on its continued safety and efficacy, also in a more complex...

EuroPCR 2018: Positive data for renal denervation reignites interest in...

After two studies indicated that renal denervation lowers blood pressure both with and without antihypertensive drugs, Felix Mahfoud (Klinik für Innere Medizin III, Saarland...

EuroPCR 2018: Two studies provide support for HeartFlow Analysis

New data from the PACIFIC study presented at EuroPCR (22 May – 25 May, Paris, France) showed that the HeartFlow Analysis had the highest...

Intravascular Lithotripsy for coronary artery disease launched in Europe

Intravascular Lithotripsy (Shockwave Medical) is now available, on the European market, for the management of calcified coronary artery disease. Additionally, according to a press...

“Excellent valvular function” with NaviGate’s GATE tricuspid valved stent at...

A press release reports that the first patient to receive the GATE tricuspid valved stent (NaviGate) via transjugular access has reached one-year post-procedure with...

Enrolment of US early feasibility study of AccuCinch system for left...

Ancora Heart has announced the expansion of its US feasibility study to evaluate the investigational AccuCinch ventricular repair system designed for the treatment of...

EuroPCR 2018: Boston Scientific outlines its key presentations

Boston Scientific Corporation has revealed its schedule of key presentations—including two late-breaking clinical trials—that will be featured at the 2018 EuroPCR (22–25 May, Paris,...

First patient treated in first-in-man study of ChordArt mitral valve repair...

CoreMedic has announced the start of the first-in-man Chagall study to evaluate the new minimally-invasive valve repair technology ChordArt. A press release reports that...

Use of Resolute Onyx to be explored for the treatment of...

Medtronic has announced the initiation of a clinical study in the US to assess the safety and efficacy of drug-eluting stents for the treatment...

EuroPCR 2018: First-in-human study of Leaflex Performer for aortic stenosis initiated

Pi-Cardia has recently started its first-in-human study with its Leaflex Performer catheter system. According to a press release, the Leaflex Performer is a transfemoral catheter...

Signal that left radial access reduces the risk of PCI-related stroke

A new study shows that patients who undergo percutaneous coronary intervention (PCI) via left radial access have a similar risk of in-hospital/30-day mortality, major...

CoreValve shows “favourable performance” at long-term follow-up

Erik W Holy (Heart Center, Segeberger Kliniken, Bad Segeberg, Germany) and others report in EuroIntervention that the CoreValve self-expanding transcatheter aortic valve implantation (TAVI)...

Cardiac Dimensions appoints Matthew Stark as vice president of Clinical and...

Cardiac Dimensions has appointed Matthew Stark as vice president of clinical and regulatory affairs, and has also appointed Trevor Moody to its board of...

Japan’s Ministry of Health Labour and Welfare grants national reimbursement for...

Abbott has announced that Japan’s Ministry of Health Labour and Welfare (MHLW) has granted national reimbursement for Xience Sierra, the newest generation of the...

Only 16% of patients participate in a formal exercise programme after...

According to a study published in Circulation, among more than 230,000 cardiac patients who had sustained a myocardial infarction or undergone one of two...

Cardioband becomes first-ever transcatheter tricuspid system to receive the CE mark

Edwards Lifesciences has received the CE mark for the Cardioband tricuspid valve reconstruction system for the treatment of tricuspid regurgitation. The approval means that...

SCAI 2018: David A Cox becomes Society’s new president

David A Cox, (Brookwood Baptist Health, San Antonio, USA; Cardiovascular Associates of the Southeast, Birmingham, USA) has assumed office as 2018–19 president of...

SCAI 2018: 3D model could be used to predict paravalvular leak...

A new study presented at the 2018 Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions (25–28 April, San Diego, USA) indicates 3D printing...

Ticagrelor may be an effective tool for suppressing platelet reactivity after...

Speaking at the 2018 CRT meeting (3–6 March, Washington, DC), Victor Alfonso Jiménez Díaz (Cardiovascular Research Unit, Cardiology Department, Hospital Alvaro Cunqueiro University Hospital of Vigo,...

Non-emergent, uncomplicated target lesion revascularisation significantly increases mortality

Patients who require non-emergent, uncomplicated target lesion revascularisation after percutaneous coronary intervention (PCI) have a significantly increased risk of mortality compared with patients who...

TMVI in inoperable patients is feasible but mortality high at one...

One-year outcome data for transcatheter mitral valve implantation (TMVI), in inoperable patients, indicate most patients who survive the first 30 days after the procedure...

Terumo receives CE mark for Ultimaster Tansei drug-eluting stent

Terumo has received the CE mark for its Ultimaster Tansei drug-eluting stent. Building on the Ultimaster stent, a press release reports, the Ultimaster Tansei features optimised...

Take care from start to finish: Avoiding radial artery occlusion

Root cause analysis of radial occlusion points to vessel trauma. An ultrasound study by Costa et al demonstrated that in the setting of a...

TAVI is increasingly seen as the preferred approach for aortic valve...

A review of the trends in the use and propensity-matched analysis of in-hospital outcomes, published in Circulation: Cardiovascular Interventions, indicates that the number of...

From the heart of the Andes to the hearts of children

Roberto Canessa is one of 16 survivors from Uruguayan Air Force Flight 571, which crashed into the Andes Mountains on 13 October 1972. He...

Study to explore shortest-ever duration of triple therapy after PCI

The COBRA REDUCE trial is exploring the safety and efficacy of prescribing dual antiplatelet therapy (DAPT) for just two weeks in high bleeding risk...

Intravascular lithotripsy: A novel technology for treating calcified coronary stenoses

Intravascular lithotripsy, or IVL (Shockwave), is a novel procedure that is designed to deliver localised pulsatile sonic pressure waves, modifying calcified lesions in a...

Boston Scientific successfully opposes Edwards Lifesciences Corporation’s European patent EP 2,399,550...

According to a press release, Boston Scientific has, along with several other opponents, successfully opposed Edwards Lifesciences Corporation's European patent EP 2,399,550 (550) in...

CE mark for HeartStitch’s transapical access and closure device

A press release reports that HeartStitch transapical access and closure device provides safe and effective percutaneous transapical access for structural heart procedures and reliable...

Medtronic appoints Laura Mauri as vice president, Global Clinical Research &...

Medtronic has announced that Laura Mauri—interventional cardiologist and clinical researcher at the Brigham and Women's Hospital, and professor of medicine at Harvard Medical School—will...

Women are still less likely to receive high-intensity statin therapy after...

New data show that, after a myocardial infarction, significantly fewer women than men fill a prescription for high-intensity statin therapy. These findings are despite...

Location of tricuspid regurgitation predicts procedural success of percutaneous edge-to-edge repair

Supporting the results of previous studies, a new study indicates that percutaneous edge-to-edge repair (MitraClip, Abbott) is a feasible approach for high-risk patients with...

A third of patients do not disclose their use of complementary...

A new study indicates that just over a third of patients with cardiovascular disease use some form of complementary therapy. Furthermore, of these patients,...

GUIDE-HF trial to evaluate whether CardioMEMS can improve survival and quality...

Abbott has initiated the landmark GUIDE-HF clinical trial using the CardioMEMS HF system. The GUIDE-HF trial will study whether the CardioMEMS device can improve...

Abiomed receives FDA approval for Impella CP with SmartAssist and Optical...

Abiomed has received US FDA premarket approval (PMA) for its Impella CP heart pump with SmartAssist, using an optical sensor. At the forefront of innovation, according...

US FDA approves Cardioform septal occluder for PFO closure to prevent...

Following the results of the Gore REDUCE clinical study, which found that closure of patent foramen ovale (PFO) can prevent recurrent ischaemic strokes, Gore...

New trial of Symplicity Spyral approved

Medtronic has announced US FDA approval to begin an investigational device exemption (IDE) pivotal trial to evaluate its Symplicity Spyral renal denervation system in...

Study of next-generation JenaValve device completes enrolment

A press release reports that successful patient enrolment in the CE mark study of the next-generation JenaValve pericardial transcatheter aortic valve implantation (TAVI) system—using...

CIT 2018: BIOFLOW-VI confirms non-inferiority of Orsiro to Xience

Nine and 12-month data for Orsiro—presented by Yang Yue Jin (Fu-Wai Hospital, National Center of Cardiovascular Disease, Beijing, China) at the China Interventional Therapeutics...

Enrolment complete in CT imaging substudy of leaflet mobility with Sapien...

Edwards Lifesciences has announced that enrolment is complete in the computed tomography (CT) imaging substudy within the PARTNER 3 trial of the Sapien 3...

First two patients enrolled in early feasibility study of second-generation Colibri...

Colibri Heart Valve has announced that the first two patients have been successfully enrolled in a clinical early feasibility study of its second-generation ready-for-use...

UK Court of Appeal dismisses Edwards Lifesciences’ appeal against Sapien 3...

Acurate neo Boston Scientific has announced the UK Court of Appeal  dismissed Edwards Lifesciences’ appeal and upheld a prior court decision that Edwards’...

Rome hospital to participate in European DuraGraft registry

The European Hospital in Rome has become the first site in Italy to participate in the DuraGraft European Registry clinical trial. The registry will...

Justin Davies

Justin Davies (Imperial College London, London, UK) has always been interested in computer programming and science and has combined these two passions in his...

More non-cardiac death explains higher rate of post-PCI mortality in females

According to a new study, the higher rate of all-cause mortality after percutaneous coronary intervention (PCI) in females relates to an excess of non-cardiac...

Evidence of substance abuse found in 10% of young myocardial infarction...

Data from the YOUNG-MI registry indicate that 10% of young myocardial infarction patients (≤50 years) have cocaine and/or marijuana in their system. These findings...

Determining valve durability in the era of TAVI

Transcatheter aortic valve implantation (TAVI) has progressed from being a procedure that was solely reserved for patients who were too high risk for surgery...

ACC 2018: Short-term DAPT after PCI in acute coronary syndrome patients...

Data from the SMART-DATE study indicate that acute coronary syndrome patients who receive short-term (six months) dual antiplatelet therapy (DAPT) after percutaneous coronary intervention...

ACC 2018: Morphologic characteristics may determine benefit of percutaneous PFO closure

A new study—presented at the American College of Cardiology (ACC) Scientific Session (10–12 March, Orlando, USA) and published in the Journal of the American...

ADVERTORIAL: “All patients” should receive cerebral protection when undergoing TAVI procedures

Data indicate that patients who undergo TAVI with the Sentinel Cerebral Protection System (Claret Medical) have a significantly higher rate of stroke-free survival than...

Enrolment complete in BIOSTEMI study

Biotronik has announced that patient enrolment for the BIOSTEMI study has been completed. A press release explains that BIOSTEMI—a randomised, controlled superiority study—is the...

ACC 2018: Using iFR over FFR saves US$896 per patient per...

Economic data from the DEFINE FLAIR clinical trial indicate that using instantaneous wave-free ratio (iFR) provides one-year average cost savings of US$896 per patient...

ACC 2018: Five-year data for CoreValve show strong haemodynamic performance

New data from the CoreValve US Pivotal Extreme Risk Study and the real-world NOTION trial (Nordic aortic valve intervention Trial)—both of which examined patients...

FDA approves the world’s smallest mechanical heart valve

The US FDA has approved the Masters HP 15mm rotatable mechanical heart valve (Abbott), which a press release says is the world’s smallest mechanical...

ACC 2018: Four-step protocol improves outcomes in STEMI patients and eliminates...

Woman patient
Umesh Khot (Cleveland Clinic, Cleveland, USA) and colleagues found that implementing a four-step protocol for managing ST-segment elevation myocardial infarction (STEMI) not only improved...

ACC 2018: Alirocumab reduces cardiovascular events in high-risk patients

The ODYSSEY OUTCOMES trial met its primary endpoint, demonstrating that high-risk patients who received alirocumab (Praluent, Sanofi) on top of their maximally-tolerated statin dose...

ACC 2018: C Michael Valentine become new president of the American...

C Michael Valentine is the new president of the American College of Cardiology (ACC), officially assuming his role at the end of the 2018...

Sapphire II PRO becomes US’s first and only 1mm coronary balloon

Cardiovascular Systems has announced that the US FDA has granted 510(k) clearance for the OrbusNeich 1mm Sapphire II PRO coronary balloon. The approval means...

HeartFlow enters into licensing agreement with Cedars-Sinai for AutoPlaque technology

HeartFlow has entered into a licensing and technology transfer agreement with Cedars-Sinai in Los Angeles (USA) for AutoPlaque technology—a software tool used to detect...

Cardiogenic shock patients would benefit the most from reducing contact-to-balloon time

Data from the FITT-STEMI (Feedback intervention and treatment times in ST-segment elevation myocardial infarction) trial indicate that reducing the time between first medical contact...

“Favourable” in-hospital outcomes for younger patients undergoing TAVI

Registry data for younger patients—under 75 years—undergoing transcatheter aortic valve implantation (TAVI) is associated with similar in-hospital outcomes to propensity-matched patients undergoing surgical aortic...

Myocardial infarction patients may benefit from having anxiety

Karl-Heinz Ladwig (Technical University of Munich and Helmholtz Zentrum München, Munich, Germany) and his fellow investigators have found that anxiety may be an effective...

CE mark for 2.5mm Fantom Encore bioresorbable scaffold

According to a press release, Reva Medical has received the CE mark for its 2.5mm Fantom Encore bioresorbable scaffold and that the scaffold has...

New “Corrie” app may reduce readmissions after myocardial infarction

According to a study presented at the American College of Cardiology’s Cardiovascular Summit (22–24 February, Las Vegas, USA), a new smartphone app may help...

Following FDA approval, Resolute Onyx 2mm becomes smallest stent on US...

Designed specifically for small vessels, the Resolute Onyx 2mm drug-eluting stent has received US FDA approval and, consequently, has been launched on to the...

Cardiovascular News Issue 48—March 2018 US edition

In this edition of Cardiovascular News (issue 48, US edition), we report on the top stories from TCT 2017—including: ORBITA, CULPRIT-SHOCK and the cost-effectiveness data from...

Cardiovascular News Issue 48—March 2018

In this edition of Cardiovascular News (issue 48), we report on the top stories from TCT 2017—including: ORBITA, CULPRIT-SHOCK and the cost-effectiveness data from...

Edwards’ self-expanding Centera TAVI valve now on European market

Edwards Lifesciences has received the CE mark for its self-expanding Centera transcatheter aortic valve implantation (TAVI) valve for severe, symptomatic aortic stenosis patients at...

Short-term DAPT is feasible for patients undergoing percutaneous LAA closure

Felix Weise (Cardioangiologisches Centrum Bethanien, Frankfurt, Germany) and others report in EuroIntervention that a strategy of six weeks’ duration of dual antiplatelet therapy (DAPT)...

New-onset atrial fibrillation after CABG significantly increases the risk of death...

New data from the EXCEL trial, which found that percutaneous coronary intervention (PCI) was non-inferior to coronary artery bypass grafting (CABG) at three years...

Fifty US centres are now using Claret Medical’s Sentinel cerebral protection...

Since it received FDA clearance in June 2017, the Sentinel cerebral protection system (Claret Medical) has become an emerging standard of care in the...

Abiomed receives expanded FDA approve for high-risk PCI procedures

Abiomed has received an expanded US FDA premarket approval for the Impella 2.5 and Impella CP heart pumps during elective and urgent high-risk percutaneous coronary...

First patient enrolled in trial reviewing 28-day DAPT with Xience

The first patient has been enrolled in a clinical trial evaluating 28 days of dual antiplatelet therapy (DAPT) in patients at high risk of...

LivaNova to buy TandemLife

LivaNova has entered into an agreement to acquire TandemLife, a privately held company focused on advanced cardiopulmonary temporary support solutions. A press release reports...

Patient enrolment at UK sites of European DuraGraft registry initiated

Somahlution has announced that Golden Jubilee National Hospital and Victoria Blackpool Hospital in the UK have initiated patient enrolment in the DuraGraft European registry...

American College of Cardiology expand programme to lower readmission rates after...

According to an American College of Cardiology (ACC) press release, hundreds of hospitals across the USA will have access to tools and resources to...

Ticagrelor significantly reduces the risk of MACE in myocardial infraction patients...

A new subanalysis of the phase III PEGASUS-TIMI 54 trial indicates that ticagrelor (Brilique, AstraZeneca), in combination with low-dose aspirin, is associated with a ...

BioVentrix now has 2018 NUB Reimbursement Status 1 in Germany for...

BioVentrix has announced a significant reimbursement achievement. InEk, the German Institute for Hospital Remuneration, has reconfirmed the award of NUB Status 1 for the...

ISET 2018: OPTALYSE PE trial reinforces safety and efficacy of EKOS...

BTG reported that the OPTALYSE PE one-year trial results, presented at ISET (3–5 February, Hollywood, USA), confirm that bilateral pulmonary embolism patients treated in...

Stress response may be reason for link between traffic noise and...

Thomas Munzel (Department of Internal Medicine, University Medical Center Mainz, Johannes Cutenberg University, Mainz, Germany) and others report in the Journal of the American...

Siemens Healthineers and Circle Cardiovascular Imaging announce joint development plan for...

At the 2018 Joint EuroCMR/SCMR meeting (31 January–3 February, Barcelona, Spain), which brings together top clinicians and researchers within the cardiovascular and MRI communities,...

More than 185 million patients now have access to HeartFlow FFRct

HeartFlow has revealed that seven new commercial payers issued positive medical policies covering the use of the HeartFlow FFRct analysis following a coronary computed...

Depression significantly increases mortality after aortic valve replacement

Data from the FRALITY-AVR (Frality aortic valve replacement) study suggest that the presence of depression in patients undergoing aortic valve replacement—either via surgery or...

Laboratory-confirmed influenza significantly increases the risk of acute myocardial infarction

Jeffrey C Kwong (Institute for Clinical Evaluative Sciences, Toronto, Canada) and others report in The New England Journal of Medicine that patients with laboratory-confirmed...

Key interventional cardiologists come together to form medical advisory board for...

Robocath—a company that conceives and develops cardiovascular robotic systems for the treatment of vascular diseases—has announced the creation of its medical advisory board, including...

US FDA grants BioCardia IDE approval for the CardiAMP chronic myocardial...

BioCardia has announced that the US FDA has approved an investigational device exemption (IDE) for the CardiAMP chronic myocardial ischaemia (CMI) trial to treat...

First patient enrolled in Tryton post-approval study

According to a press release from Tryton Medical, the first patient has been enrolled in the post approval study to evaluate the Tryton side-branch...

Corindus Vascular Robotic to co-sponsor courses on transradial coronary interventions

Corindus Vascular Robotics will be co-sponsoring courses at multiple leading hospitals to educate interventional cardiologists on transradial access techniques and robotic-assisted vascular interventions. The course...

Telemark microcatheter receives US FDA approval

Surmodics has received US FDA 510(k) clearance for its Telemark .014inch coronary support microcatheter. A press release reports that the company is making the...

Patients who have an in-hospital cardiac arrest at the weekend continue...

Woman patient
Uchenna R Ofoma (Geisinger Health System, Danville, USA) and others report in the Journal of the American College of Cardiology that patients who have...

Boston Scientific enters into an acquisition option agreement with Millipede

Boston Scientific has closed an investment and entered into an acquisition option agreement with Millipede, which has developed the “IRIS” transcatheter annuloplasty ring system...

Japanese Ministry of Health approve Biotronik’s Orsiro drug-eluting stent

According to a Biotronik press release, the Japanese Ministry of Health has approved the company’s Orsiro coronary stent—a sirolimus-eluting stent with a biodegradable polymer—for...

ESC 2018: Society calls for abstract submissions for its next congress

The European Society of Cardiology (ESC) has released a new video, see below, that outlines the reasons why physicians should consider submitting an abstract...

Prediabetes significantly increases risk of events after PCI

An all-comers study of patients undergoing percutaneous coronary intervention (PCI) with contemporary drug-eluting stents indicates that those with prediabetes have a significantly higher risk...

Next-day discharge appears safe for TAVI patients without in-hospital complications

Patients who undergo transfemoral transcatheter aortic valve implantation (TAVI) with a minimalist approach and who are discharged the day after the procedure have similar...

First US commercial implants of Elunir drug-eluting stent performed

Cordis and Medinol have announced that the first US commercial cases using the Elunir drug-eluting stent have taken place at New York-Presbyterian Hospital/Columbia University...

Mayo Clinic using robot-assisted PCI for preclinical study on “telestenting”

Corindus Vascular Robotics has announced that it is working with Mayo Clinic in a preclinical study about use of telestenting. A press release reports...

First patient enrolled in OPTIMIZE study of Svelte drug-eluting stent integrated...

The Christ Hospital, Lindner Research Center in Cincinnati, USA, has enrolled the first patient in Svelte Medical System’s OPTIMIZE clinical study; the study is...

Second myocardial infarction twice as likely to occur non-culprit artery than...

The results of PRECLUDE, an analysis of data from the ongoing SWEDEHEART quality registry, show that in people with multivessel disease, the risk of...

First-in-human implantation of the Cordella pulmonary artery pressure sensor performed

Endotronix has announced successful first-in-human implantation of the Cordella pulmonary artery pressure sensor and the initiation of the SIRONA first-in-human (FIH) clinical trial. Wilfried...

Acarix announces start of multicentre trial for handheld CADScor system

Acarix started the initiation of a multicentre trial of its handheld CADScor system, which is designed to provide non-invasive, non-radiation acoustic detection of coronary...

Sixty-day follow-up for the MANTA US pivotal trial completed

Essential Medical has announced the completion of the 60-day follow up for its MANTA US pivotal study. Manta is vascular closure device and is...

Team-centred approach is best way of determining need for PFO closure

A meta-analysis, published in The American Journal of Medicine, provides further evidence that percutaneous closure of patent foramen ovale (PFO) in patients with recent...

Miracor Medical raises €25M to support clinical and prepare commercial activities

Miracor Medical Systems and Miracor Medical have announced the closing of € 25m as part of a Series D financing round. The new capital...

Recommendations for the use of embolic protection devices during saphenous vein...

A meta-analysis—published in Circulation Cardiovascular Interventions—indicates that the routine use of an embolic protection device during percutaneous coronary intervention (PCI) in a saphenous vein...

Modifying procedural technique during TAVI may lower radiation exposure to patients

Andrew Goldsweig (Division of Cardiology, University of Nebraska Medical Center, Omaha, USA) and others report in Catheterization and Cardiovascular Interventions that eight factors are...

Promising results for RenalGuard in heart failure patients

According to a press release, a first-in-man feasibility study focusing on a novel use of the RenalGuard system to manage fluids during diuretic therapy...

London’s Science Museum honours 50 years of heart transplants

The Science Museum (London, UK) has unveiled a special exhibit to commemorate the 50th anniversary of the world’s first heart transplant, which took place...

Health Care Service Corporation deem that FFRCT may be a “medically...

HeartFlow has announced that the Health Care Service Corporation (HCSC)—that operates Blue Cross and Blue Shield plans in Illinois, Montana, New Mexico, Oklahoma and...

Janssen seeks approval for rivaroxaban to be used to reduce cardiac...

Janssen has submitted a supplemental new drug application to the US FDA for two new indications for rivaroxaban (Xarelto, which is marketed by Bayer in...

Apple and Stanford Medicine launch app-based arrhythmia study

Apple has launched the Apple Heart Study app, a first-of-its-kind research study using Apple Watch’s heart rate sensor to collect data on irregular heart rhythms and...

M Lewis Kinard appointed as executive vice president, general counsel and...

The American Heart Association (AHA) has named attorney M Lewis Kinard as executive vice president, general counsel and assistant corporate secretary for the organisation...

Philips acquires cloud-based population health management solution provider VitalHealth

Philips has acquired VitalHealth, a provider of cloud-based population health management solutions for the delivery of personalised care outside of the hospital. Headquartered in...

ICI 2017: Novel transcatheter mitral valve wins Best Technology Parade Presentation

4C Medical Technologies has won the Best Technology Parade Presentation award—at  the 2017 Innovations in Cardiovascular Interventions (ICI) meeting (3–5 December, Tel Aviv, Israel)—for...

Acute iFR evaluation may be a valid approach for ruling out...

The iSTEMI study, published in JACC: Cardiovascular Interventions, suggests that instantaneous wave-free ratio (iFR) in the acute setting—ie. immediately after successful primary percutaneous coronary...

Pollution may derail benefits of walking in older adults

Fan Chung (National Heart & Lung Institute, Imperial College London, UK) and colleagues report in The Lancet that even short-term  (two-hour) exposure to tiny...

Global survey indicates that patients with type 2 diabetes underestimate their...

According to the interim results of the first-ever multi-country online survey on cardiovascular disease risk awareness and knowledge among people living with type 2...

“Vast majority” of young myocardial infarction patients do not meet criteria...

Avinainder Singh (Brigham and Women’s Hospital, Harvard Medical School, Boston, USA) and others report in the Journal of the American College of Cardiology that...

STEMI patients at highest risk are less likely to receive optimal...

Data from the regional emergency cardiovascular (RESCUe) network indicate that patients who have had a ST-segment elevation myocardial infarction (STEMI) and who are increased...

EpicHeart soft-robotic heart assist device wins innovation award

CorInnova has been awarded second prize in the “2017 InnoSTARS” life science competition for its EpicHeart soft-robotic heart assist device. The on-blood-contacting device is...

TCT 2017: The HREVS study provides supportive evidence for the hybrid...

The HREVS (Hybrid coronary revascularisation vs. standard) trial found that there was no significant difference between percutaneous coronary intervention (PCI), coronary artery bypass grafting...

TCT 2017: FAME 2 provides support for PCI in stable disease...

Following ORBITA, which indicated percutaneous coronary intervention (PCI) did not provide benefit over a sham procedure in patients with stable coronary artery disease, the...

Evolocumab becomes first PCSK9 inhibitor to be approved for use in...

The US FDA has approved evolocumab (Repatha, Amgen) for the prevention of myocardial infarction, strokes and coronary revascularisations in adults with established cardiovascular disease....

TCT 2017: Advances in device technology needed to improve outcomes with...

Data from the ABSORB IV study indicate that device thrombosis with the bioresorbable vascular scaffold (Absorb, Abbott) is substantially reduced when the device is...

Artificial intelligence is being explored as a new tool for diagnosing...

We are witnessing a new era in which artificial intelligence is being applied to areas of research, imaging, diagnostics, and treatment. In cardiovascular medicine,...

Report calls for US to prioritise health resources towards diagnosing and...

A report—modified from US global health recommendations from the National Academies of Sciences, Engineering and Medicine (previously the Institute of Medicine) and published in...

Elunir drug-eluting stent approved for use in the USA

Cordis and Medinol have announced that the US FDA has approval the Elunir drug-eluting stent for the treatment of patients with coronary artery disease....

Inhaled Xenon plus hypothermia may reduce myocardial injury after an out-of-hospital-cardiac...

NeuroproteXeon has announced the publication of a second finding from a randomised, controlled phase II trial of inhaled xenon and oxygen, combined with hypothermia,...

China’s first human implantation of a retrievable TAVI device successfully completed

The first human implantation of the VenusA Plus retrievable valve system was completed successfully at the Second Affiliated Hospital of Zhejiang University School of...

“We really believe that the transradial approach is a better way...

The Society for Cardiovascular Angiography and Interventions (SCAI) has launched a new initiative, supported by Medtronic, called “Transition for value” that aims to help...

Interventional cardiology in the Twitterverse

The past few years has witnessed increasing clinician engagement with social media platforms, including Twitter (which, overall, has 300 million active users). Well-known “Tweeters”...

Boston Scientific pushes back plans for commercialisation of Lotus Edge TAVI...

Boston Scientific has announced a delay to the previously communicated timelines for the commercialisation of its Lotus Edge transcatheter aortic valve implantation (TAVI) device...

US patients have had more preventive care for cardiovascular disease under...

Joseph Ladapo (David Geffen School of Medicine, University of California, Los Angeles, USA) and others report in American Journal of Managed Care that—by reducing...

TCT 2017: TMVI in mitral ring is a reasonable alternative for...

Data from the MITRAL (Mitral Implantation of Transcatheter valves) study indicate that transeptal transcatheter mitral valve implantation (TMVI), with a Sapien 3 device (Edwards...

TCT 2017: Vivek Reddy on the final outcomes of PREVAIL and...

Boston Scientific has announced the final five-year outcomes data from the PREVAIL study during a late-breaking clinical trial session at this year’s Transcatheter Cardiovascular Therapeutics (TCT;...

Francesco Maisano

Francesco Maisano (University Heart Centre, University Hospital Zurich Zurich, Switzerland) works on the border between surgery and interventions; he embraces heart team challenges and...

AHA 2017: Widely used approach for preventing renal complications after angiography...

Data from PRESERVE (Prevention of serious adverse events following angiography) indicate that neither intravenous sodium bicarbonate nor acetylcysteine, compared with saline and placebo, reduce...

AHA 2017: Novel transcatheter therapy for heart failure shows promise in...

Primary results from the REDUCE LAP-HF trial indicate that a novel interatrial shunt device (IASD, Corvia Medical) significantly reduced pulmonary capillary wedge pressure (PCWP)...

Creavo wins two awards for its cardiac imaging device

Creavo's Vitalscan
  Creavo Medical Technologies (Creavo) has won two awards at the Institution of Engineering and Technology (IET) Innovation awards (15 November, London, UK) for its...

A bold new study could alter the orbit of elective PCI

The ORBITA (Objective randomised blinded investigation with optimal medical therapy of angioplasty in stable disease) study, recently presented at 2017 Transcatheter Cardiovascular Therapeutics (TCT)...

AHA 2017: Nutty eating habits may lower the risk of cardiovascular...

A study published in the Journal of the American College of Cardiology indicates that people who regularly eat nuts—including peanuts, walnuts and tree nuts...

AHA 2017: First patients enrolled in trial of IASD system for...

Corvia Medical has enrolled the first patients in its global multicentre trial (REDUCE LAP-HF II) of the interatrial shunt device (IASD) for the treatment...

Precommercialisation of Serpentis drug-eluting stent announced

Stentys has announced the precommercialisation of its Serpentis stent. According to a press release, the sirolimus-eluting stent has a biodegradable coating and is designed...

New study shows significant clinical workflow and staff experience benefits of...

Philips has announced the results of a comprehensive, independent, two-year study demonstrating the clinical workflow benefits of its next generation image-guided therapy platform, Azurion. The...

AHA 2017: Fun in the bedroom is unlikely to cause a...

Data published, as a research letter, in the Journal of the American College of Cardiology and presented at the American Heart Association’s Scientific Sessions...

Neovasc receive approval to initiate COSIRA-II IDE clinical trial

Neovasc has received approval of the US FDA to initiate the COSIRA-II IDE clinical trial.  The trial's purpose will be to demonstrate the safety...

TCT 2017: Sham-controlled trial raises doubts about benefit of angiography-guided PCI...

ORBITA (Objective randomised blinded investigation with optimal medical therapy of angioplasty in stable disease)—the first-ever sham controlled trial of percutaneous coronary intervention (PCI)—indicates that...

TCT 2017: Study challenges recommendations on the management of cardiogenic shock

Advice on percutaneous coronary intervention (PCI) strategies for patients with acute myocardial infarction complicated by cardiogenic shock may need to be revised after the...

MitraClip becomes first approved device for transcatheter mitral valve repair in...

Abbott has announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has appro